-
Publication Venue For
-
COVID-19 and its implications for thrombosis and anticoagulation..
135:2033-2040.
2020
-
Assessing Feasibility of a Focused Geriatric Assessment in Older Adults with Sickle Cell Disease to Address Functional Risk Factors for Morbidity and Mortality.
134:518-518.
2019
-
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas..
131:68-83.
2018
-
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
128:3083-3100.
2016
-
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma..
128:3083-3100.
2016
-
GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo.
127:2723-2731.
2016
-
Altered lymphopoiesis and immunodeficiency in miR-142 null mice..
125:3720-3730.
2015
-
Cerebral Ischemia in Adults with Sickle Cell Disease after First Stroke.
124.
2014
-
Health-Related Quality of Life in Children with Sickle Cell Disease: Impact of Blood Transfusion Therapy.
124.
2014
-
Impact of Comorbidities on Length of Stay and Mortality in Hospitalized Patients with Cancer and Febrile Neutropenia.
124.
2014
-
MEK Inhibitors, Novel Anti-Adhesive Molecules, Reverse Sickle Red Blood Cell Adhesion and Vaso-Occlusion in Vivo.
124.
2014
-
Patent Foramen Ovale in Adult Patients with Sickle Cell Disease and Stroke.
124.
2014
-
Prognostic Disclosure in Acute Myeloid Leukemia (AML): A Qualitative Study of Patient Preferences and Physician Practices.
124.
2014
-
The DOT1L Inhibitor EPZ-5676: Safety and Activity in Relapsed/Refractory Patients with MLL-Rearranged Leukemia.
124.
2014
-
The Use of Chronic Transfusions in Sickle Cell Disease for Non-Stroke Related Indications.
124.
2014
-
Venous Thromboembolism (VTE) Surveillance: Incidence, Characteristics, and Initial Treatment of VTE Patients.
124.
2014
-
Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.
124:1915-1925.
2014
-
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL..
121:4521-4528.
2013
-
Impact of hydroxyurea on clinical events in the BABY HUG trial..
120:4304-4448.
2012
-
Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia..
120:748-760.
2012
-
Control of GVHD: It's in our DNA!.
119:1102-1103.
2012
-
Development of a Quality of Life Instrument Specific for Cutaneous Lymphoma.
118:3158-3158.
2011
-
Gene-expression patterns predict phenotypes of immune-mediated thrombosis (Blood (2006) 107, 4, (1391-1396)).
118:4497.
2011
-
Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence..
117:4142-4153.
2011
-
C/Ebpa Gene Mutation and C/Ebpa Promoter Hypermethylation in Acute Myeloid Leukemia with Normal Cytogenetics..
114:1570-1570.
2009
-
Response: Variability in the prevalence of Chlamydophila psittaci infection in patients with OAML.
114:3499-3500.
2009
-
A Multicenter, Randomized, Dose Frequency Study of the Safety and Efficacy of Cerezyme (R) Infusions Every 4 Weeks Versus Every 2 Weeks in the Maintenance Therapy of Patients with Type 1 Gaucher Disease.
112:460-460.
2008
-
A Phase I/II Study with CP-4055 in Patients with Haematologic Malignancies..
112:350-350.
2008
-
Adherence with Hydroxyurea in Children with Sickle Cell Disease.
112:69-69.
2008
-
Antecedent Transfusion and Primary Hemorrhagic Stroke in Adults with Sickle Cell Disease..
112:512-512.
2008
-
Apolipoprotein E-Mimetic Therapeutic Peptides Mediate CLL Cell Cytotoxicity.
112:140-140.
2008
-
Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma.
112:1142-1142.
2008
-
Complications of Hysterectomy in Women with Von Willebrand Disease.
112:1166-1166.
2008
-
Development of mPF4/Heparin Antibodies in a Murine Platelet Activation Model.
112:106-107.
2008
-
Differential Impact of Inhibitory and Activating Killer Ig-Like Receptors and HLA Ligand on Outcomes of Transplantation for Myeloid and Lymphoid Malignancies.
112:1118-1118.
2008
-
Does Living Closer to a Medical Care Center Matter in Sickle Cell Disease?.
112:323-324.
2008
-
Early Pre/Post Fluoro-Deoxyglucose Positive Emission Tomography (PET) Does Not Predict Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation in Hodgkins Disease and Non-Hodgkins Lymphoma.
112:760-760.
2008
-
Encoraging Results after Alternative Donor Transplantation for Myelodysplastic Syndrome.
112:685-686.
2008
-
Erythrocyte Adhesion and Phosphatidylserine Exposure in HbSC Disease: Baseline Data from the CHAMPS Study..
112:861-861.
2008
-
Escalating Dose Intravenous Methotrexate without Leucovorin Rescue during Interim Maintenance Is Superior to Oral Methotrexate for Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): Children’s Oncology Group Study 1991.
112:9-9.
2008
-
Family-Associated Monoclonal B Lymphocytosis Is Commonly Oligoclonal and Expresses Markers Associated with Adverse Risk in CLL.
112:1078-1078.
2008
-
Functional and Biochemical Changes in Stored Human Red Blood Cells.
112:1355-1355.
2008
-
Gene Expression Profiles with Signatures of Tumor Biology and Chemotherapy Sensitivity May Provide a Novel Approach to Maximize Response to Induction Therapy in Patients with Acute Myeloid Leukemia.
112:785-786.
2008
-
Genomic Approaches to Identifying Risk for Pulmonary Artery Hypertension among Individuals with Sickle Cell Disease..
112:514-514.
2008
-
Identification of Therapeutic Targets for Chronic Lymphocytic Leukemia in the Relapsed and Refractory Setting.
112:720-720.
2008
-
Increased Hepcidin Expression in Mice Affected by beta-Thalassemia Reduces Iron Overload with No Effect on Anemia.
112:53-53.
2008
-
Isolation and Expansion of Oligodendrocytes from Thawed, Cryopreserved Human Umblilical Cord Blood.
112:1193-1193.
2008
-
MicroRNAs Distinguish Burkitt Lymphoma from the Molecular Subsets of Diffuse Large B Cell Lymphoma.
112:1151-1151.
2008
-
MicroRNAs Regulate Mature B Cell Differentiation.
112:262-262.
2008
-
Monocytes Are a Particularly Favorable Target for Surface Platelet Factor 4 (PF4) Antigenic Complex Formation in Heparin-Induced Thrombocytopenia: New Insights into the Thrombotic Risk in HIT.
112:107-107.
2008
-
Obstetric and Gynecological History in Sickle Cell Disease Females.
112:867-868.
2008
-
Patients Are Willing to Trade off Efficacy, Safety, and Administration Attributes of Chronic Idiopathic Purpura (ITP) Therapy: Results from a Large North American Discrete Choice Study.
112:669-669.
2008
-
Plasmacytoid CD123+Dendritic Cell Recovery Is An Independent Predictor of Survival after Unrelated Cord Blood Transplant (UCBT).
112:777-777.
2008
-
Prolonged Survival despite High Disease Burden in Elderly (>= 55) Patients with Hb SS or Hb S beta 0 Thalassemia.
112:264-264.
2008
-
Safety Trial of NK Cell Enhanced Donor Lymphocyte Infusions from a 3-5/6 HLA Matched Family Member Following Nonmyeloablative Allogeneic Stem Cell Transplantation.
112:133-134.
2008
-
Secondary Acute Myeloid Leukemia (sAML) Treated with Amonafide (AS1413) + Cytarabine: Durable Responses in Poor-Risk AML.
112:1019-1020.
2008
-
Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients..
111:4209-4219.
2008
-
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia..
111:3991-3997.
2008
-
Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group..
111:2984-2990.
2008
-
IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival..
111:2101-2111.
2008
-
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria..
111:1840-1847.
2008
-
Perivascular tissue factor is down-regulated following cutaneous wounding: implications for bleeding in hemophilia..
111:2046-2048.
2008
-
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia..
111:1584-1593.
2008
-
Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase..
111:1497-1503.
2008
-
Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells..
111:723-731.
2008
-
Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1)..
111:209-218.
2008
-
Determinants of PF4/heparin immunogenicity..
110:4253-4260.
2007
-
Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity..
110:4341-4350.
2007
-
Risk factors for primary hemorrhagic stroke in adults with sickle cell disease.
110:19B-20B.
2007
-
Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1..
110:3706-3714.
2007
-
Are 2 cords better than 1?.
110:2789-2790.
2007
-
Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo..
110:2708-2717.
2007
-
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)..
110:1713-1722.
2007
-
Genetic-based dosing in orthopedic patients beginning warfarin therapy..
110:1511-1515.
2007
-
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201..
110:1105-1111.
2007
-
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study..
110:1388-1396.
2007
-
TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)..
110:479-484.
2007
-
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801..
109:5136-5142.
2007
-
Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin..
109:5027-5035.
2007
-
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511..
109:4164-4167.
2007
-
Of mice and iron: Ferroportin disease.
109:4115.
2007
-
Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants..
109:4539-4547.
2007
-
Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation..
109:4038-4044.
2007
-
Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications..
109:3595-3602.
2007
-
T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3zeta subunit of the T-cell antigen receptor complex..
109:3198-3206.
2007
-
Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse..
109:3115-3123.
2007
-
Transplantation of vascular endothelial cells mediates the hematopoietic recovery and survival of lethally irradiated mice..
109:2365-2372.
2007
-
Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification..
109:1559-1567.
2007
-
Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm..
109:1381-1386.
2007
-
The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages..
109:1620-1626.
2007
-
Evidence for an immune barrier after in utero hematopoietic-cell transplantation..
109:1331-1333.
2007
-
Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report..
109:503-506.
2007
-
CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation..
108:4268-4274.
2006
-
Treg-cell expansion: Better to be "naive".
108:3963-3964.
2006
-
Bleeding.Events and other complications during pregnancy and childbirth in women with Von Willebrand disease..
108:302A-302A.
2006
-
Blocking adhesion of sickle erythrocytes to endothelial alpha V beta 3 using RNA aptamer..
108:206A-207A.
2006
-
Genetic polymorphisms associated with priapism in sickle cell disease..
108:236A-237A.
2006
-
Predictors of Acute Intracranial Pathology Identified by Computerized Tomography in Children with Sickle Cell Disease..
108:3798-3798.
2006
-
The Addition of Fludarabine to a Conventional Busulfan/Melphalan/Anti-Thymocyte Globulin (Flu/Bu/Mel/ATG) Preparative Regimen Increased Engraftment without Additional Toxicity..
108:2944-2944.
2006
-
Cutaneous wound healing is impaired in hemophilia B..
108:3053-3060.
2006
-
Interleukin-6 induces hepcidin expression through STAT3..
108:3204-3209.
2006
-
Oral Forodesine (Bcx-1777) Is Clinically Active in Refractory Cutaneous T-Cell Lymphoma: Results of a Phase I/II Study..
108:2467-2467.
2006
-
Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26..
108:1602-1610.
2006
-
In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes..
108:1770-1773.
2006
-
Lepirudin: Walking the dosing line.
108:1428-1429.
2006
-
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure..
108:1421-1423.
2006
-
Deferasirox versus deferoxamine..
108:774-775.
2006
-
Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA)..
108:379-381.
2006
-
Role of transforming growth factor-beta in hematologic malignancies..
107:4589-4596.
2006
-
Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes..
107:4491-4499.
2006
-
Improved outcome in CNS aspergillosis, using voriconazole [5].
107:3411-3412.
2006
-
Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice..
107:2952-2958.
2006
-
Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications..
107:2346-2353.
2006
-
Gene-expression patterns predict phenotypes of immune-mediated thrombosis..
107:1391-1396.
2006
-
Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling..
106:4315-4321.
2005
-
The role of duodenal cytochrome b in intestinal iron absorption remains unclear..
106:4413.
2005
-
Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies..
106:3898-3906.
2005
-
The extracellular matrix protein mindin serves as an integrin ligand and is critical for inflammatory cell recruitment..
106:3854-3859.
2005
-
The immune paradox of fondaparinux.
106:3686-3687.
2005
-
CD molecules 2005: human cell differentiation molecules..
106:3123-3126.
2005
-
Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression..
106:2936-2943.
2005
-
Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice..
106:2879-2883.
2005
-
Improved outcome in central nervous system aspergillosis, using voriconazole treatment..
106:2641-2645.
2005
-
HCT outcomes: A new tool?.
106:2602-2603.
2005
-
Analysis of the E399D mutation in SLC11A2..
106:2221.
2005
-
Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer.
106:1552-1558.
2005
-
PF4/heparin complexes are T cell-dependent antigens..
106:929-931.
2005
-
Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34..
106:95-102.
2005
-
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222..
105:3420-3427.
2005
-
Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand..
105:3206-3213.
2005
-
Haptoglobin modifies the hemochromatosis phenotype in mice..
105:3353-3355.
2005
-
Role of Rap1 in promoting sickle red blood cell adhesion to laminin via BCAM/LU..
105:3322-3329.
2005
-
Rod mutations associated with MYH9-related disorders disrupt nonmuscle myosin-IIA assembly..
105:161-169.
2005
-
Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia..
105:131-138.
2005
-
Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism..
104:3986-3992.
2004
-
Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions..
104:3774-3781.
2004
-
Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome..
104:2783-2790.
2004
-
Your Ad here: optimizing adenoviral vector-based vaccines.
104:2612-2613.
2004
-
A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation..
104:2376-2384.
2004
-
Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome..
104:2574-2581.
2004
-
Identification of a novel mutation (C321X) in HJV..
104:2176-2177.
2004
-
Quiescent phenotype of tumor-specific CD8+ T cells following immunization..
104:1970-1978.
2004
-
A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype..
104:1909.
2004
-
Role of A91V mutation in perforin gene in hemophagocytic lymphohistiocytosis.
104:1910-1910.
2004
-
IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation..
104:775-780.
2004
-
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS..
104:857-864.
2004
-
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma..
104:642-648.
2004
-
Superoxide dismutase-3 promotes full expression of the EPO response to hypoxia..
104:43-50.
2004
-
Atypical features of familial hemophagocytic lymphohistiocytosis..
103:4610-4612.
2004
-
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia..
103:4036-4042.
2004
-
Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation..
103:4344-4352.
2004
-
Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder..
103:4243-4250.
2004
-
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells..
103:3986-3988.
2004
-
Contributions of beta2-microglobulin-dependent molecules and lymphocytes to iron regulation: insights from HfeRag1(-/-) and beta2mRag1(-/-) double knock-out mice..
103:2847-2849.
2004
-
Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice..
103:2841-2843.
2004
-
Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation..
103:2009-2018.
2004
-
Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease..
103:1534-1541.
2004
-
Donor immune reconstitution after liver-small bowel transplantation for multiple intestinal atresia with immunodeficiency..
103:1171-1174.
2004
-
Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity..
102:4137-4142.
2003
-
Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis..
102:3900-3905.
2003
-
Transferrin receptor 1 is differentially required in lymphocyte development..
102:3711-3718.
2003
-
Fatal hepatic necrosis following imatinib mesylate therapy..
102:3455-3456.
2003
-
Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells..
102:2789-2797.
2003
-
Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin..
102:2574-2580.
2003
-
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis..
102:2364-2372.
2003
-
Persistent Mycobacterium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferon-gamma receptor-1 deficiency..
102:2692-2694.
2003
-
Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells..
102:2243-2250.
2003
-
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study..
102:1613-1618.
2003
-
Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders..
102:1869-1871.
2003
-
CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes..
102:1374-1380.
2003
-
Synergy between tumor immunotherapy and antiangiogenic therapy..
102:964-971.
2003
-
Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients..
102:1121-1130.
2003
-
S-nitrosohemoglobin is distinguished from other nitrosovasodilators by unique oxygen-dependent responses that support an allosteric mechanism of action..
102:410-411.
2003
-
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System..
101:5061-5067.
2003
-
Progress with unrelated cord blood transplants in adults.
101:4648-4648.
2003
-
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression..
101:4878-4886.
2003
-
Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts..
101:3641-3647.
2003
-
Clonal expansion of CD8+ BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia..
101:3106-3108.
2003
-
Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk..
101:3008-3013.
2003
-
Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion..
101:3281-3287.
2003
-
The roles of alpha IIb beta 3-mediated outside-in signal transduction, thromboxane A2, and adenosine diphosphate in collagen-induced platelet aggregation..
101:2646-2651.
2003
-
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease..
101:2137-2143.
2003
-
Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome..
100:4337-4343.
2002
-
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)..
100:4325-4336.
2002
-
Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease..
100:3776-3781.
2002
-
Placental/umbilical cord blood for unrelated-donor bone marrow reconstitution: relevance of nucleated red blood cells..
100:2662-2664.
2002
-
Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells..
100:2159-2167.
2002
-
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes..
100:1602-1610.
2002
-
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720..
100:1224-1232.
2002
-
Regulation of iron absorption in Hfe mutant mice..
100:1465-1469.
2002
-
Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces..
100:539-546.
2002
-
Circulating and binding characteristics of wild-type factor IX and certain Gla domain mutants in vivo..
100:153-158.
2002
-
FLT3 internal tandem duplication mutations are rare in agnogenic myeloid metaplasia..
100:364.
2002
-
Platelet-dependent action of high-dose factor VIIa..
100:364-365.
2002
-
Purification and characterization of the yeast-expressed erythropoietin mutant Epo (R103A), a specific inhibitor of human primary hematopoietic cell erythropoiesis..
99:4400-4405.
2002
-
Tissue factor is the receptor for plasminogen type 1 on 1-LN human prostate cancer cells..
99:4562-4567.
2002
-
Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process..
99:3083-3088.
2002
-
A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis..
99:3066-3069.
2002
-
The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl..
99:2957-2968.
2002
-
Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII..
99:2828-2834.
2002
-
Addition of a second, different allogeneic graft accelerates white cell and platelet engraftment after T-cell-depleted bone marrow transplantation..
99:2235-2240.
2002
-
Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI..
99:1817-1824.
2002
-
Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody..
99:1230-1236.
2002
-
Adenosine deaminase deficiency with mosaicism for a "second-site suppressor" of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy..
99:1005-1013.
2002
-
Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival..
99:872-878.
2002
-
A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution..
99:364-371.
2002
-
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies..
98:3569-3574.
2001
-
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation..
98:3505-3512.
2001
-
Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen..
98:3486-3488.
2001
-
Absolute lymphoid and myeloid dendritic cell counts in umbilical cord blood, bone marrow, and peripheral blood..
98:321B-321B.
2001
-
Alemtuzumab (Campath) in relapsed or refractory CLL or PLL..
98:290B-291B.
2001
-
Binding and uptake of PF4/heparin/antibody complexes in multiple cell types..
98:35A-35A.
2001
-
Cord blood donor pre-screening: Impact of exclusion criteria on minority recruitment..
98:104B-104B.
2001
-
Correction of Hurler Syndrome with unrelated umbilical cord blood transplantation..
98:667A-667A.
2001
-
Cytokine modulation of inducible nitric oxide synthase (NOS2) mRNA levels and apoptosis in B-cell chronic lymphocytic leukemia (B-CLL): A quantitative analysis..
98:362A-362A.
2001
-
Dose dense, high intensity therapy for mantle cell lymphoma..
98:681A-682A.
2001
-
Durable engraftment of mismatched unrelated cord blood following a non-myeloablative preparative regimen for adults..
98:185A-185A.
2001
-
Enrichment of donor erythroid cells after non-myeloablative bone marrow transplantation (BMT) for sickle cell anemia (SCA)..
98:490A-490A.
2001
-
Flow cytometric analysis in two large cohorts of patients with PNH..
98:221A-221A.
2001
-
Functional T cell immunity before myeloid engraftment by donor post-thymic T cells in pediatric unrelated cord blood transplant recipients..
98:379A-379A.
2001
-
High-dose immunosuppressive therapy (HDIT) for severe systemic sclerosis (SSc)..
98:395B-395B.
2001
-
Impaired anticoagulant response to thrombin improves after regression of atherosclerosis in monkeys..
98:257A-257A.
2001
-
Increased microvessel density in non-Hodgkin's lymphoma (NHL) is localized to the site of disease changes in accordance with disease response..
98:236B-236B.
2001
-
J82 cell inositol polyphosphatide signaling via factor Xa and factor VIIa: The possible role of protease-activated receptor 2 (PAR-2) activation..
98:53B-53B.
2001
-
Lack of standardization of methodology for enumeration of CD34 in banked umbilical cord blood..
98:333B-333B.
2001
-
Low dose, weekly, paclitaxel as salvage therapy for non-Hodgkins lymphoma (NHL)..
98:246B-246B.
2001
-
MRD allo transplantation using a large volume leukopheresis product mobilized with G-CSF and Decadron, pharmacokinetics directed modest dose intravenous busulfan plus fludarabine conditioning, and long MTX/CSA results in sustained engraftment, low 30 day mortality, and low incidence of severe GVHD..
98:200A-200A.
2001
-
Molecular evidence of engraftment in bone marrow after nonmyeloablative allogeneic stem cell transplant (NMASCT) is an unreliable indicator of residual/recurrent disease in the marrow..
98:185A-185A.
2001
-
Molecular interaction of the Fanconi Anemia (FA) and Ataxia Telangiectasia (AT) pathways..
98:782A-782A.
2001
-
Multi-institutional phase II, randomized dose finding study of defibrotide (DF) in patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Promising response rate without significant toxicity in a high risk population..
98:853A-853A.
2001
-
Non-myeloablative allogeneic transplantation using T depleted matched sibling peripheral blood stem cells..
98:420A-421A.
2001
-
Non-myeloablative transplantation using CAMPATH 1H for T depletion of mismatched, related donor peripheral blood stem cells..
98:669A-669A.
2001
-
PRA reduction after sublethal preconditioning and hematopoietic reconstitution with Campath-1-treated mobilized peripheral blood..
98:315B-315B.
2001
-
Phase I trial of prolonged infusion gemcitabine with fludarabine for relapsed/refractory acute leukemia..
98:220B-221B.
2001
-
Prolonged infusion gemcitabine in combination with CPT-11 for relapsed or refractory hematologic malignancies..
98:209B-209B.
2001
-
Radiolabeled anti-tenascin antibody for refractory non-Hodgkins lymphoma (NHL)..
98:247B-247B.
2001
-
Reconstitution of T cell and dendritic cell immunity 50 days post unrelated cord blood transplant predicts the incidence of opportunistic infections and acute GVHD in children..
98:204A-204A.
2001
-
Red cell signaling pathways cause increased sickle cell adhesion to non-activated endothelial cells..
98:484A-484A.
2001
-
Regulation of T and NK cell mediated cytotoxicity by the CD7 ligand, k12..
98:23A-23A.
2001
-
Sickle red cell B-CAM/LU mediates adhesion to multiple sites of laminin under different conditions..
98:484A-485A.
2001
-
The clinical course of PNH in the USA and in Japan..
98:220A-220A.
2001
-
Translocations of the MLL gene can be detected in an increased proportion of mononuclear cells collected after etoposide priming in patients subsequently developing secondary acute leukemia..
98:401A-402A.
2001
-
Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT)..
98:687A-687A.
2001
-
Unique molecular characteristics of primitive human AML cells permit apoptosis to be specifically induced in leukemic but not normal stem cells..
98:93A-93A.
2001
-
alpha-adducin connects actin filament barbed ends to the platelet membrane skeleton..
98:787A-787A.
2001
-
Mobilization and collection of peripheral blood CD34+ cells from patients with Fanconi anemia..
98:2917-2921.
2001
-
Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA..
98:2442-2447.
2001
-
Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells..
98:2301-2307.
2001
-
Relationship between transferrin saturation and iron stores in the African American and US Caucasian populations: analysis of data from the third National Health and Nutrition Examination Survey..
98:2345-2351.
2001
-
Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL..
98:2052-2058.
2001
-
Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome..
98:1321-1325.
2001
-
Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8..
98:1252-1254.
2001
-
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine..
98:548-553.
2001
-
Differential regulation of the fibroblast growth factor (FGF) family by alpha(2)-macroglobulin: evidence for selective modulation of FGF-2-induced angiogenesis..
97:3450-3457.
2001
-
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)..
97:3574-3580.
2001
-
A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis..
97:2998-3003.
2001
-
T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation..
97:2896-2899.
2001
-
Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells..
97:2177-2179.
2001
-
Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin- 3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation..
97:1289-1297.
2001
-
Expression of the DMT1 (NRAMP2/DCT1) iron transporter in mice with genetic iron overload disorders..
97:1138-1140.
2001
-
Human equivalent of the mouse Nude/SCID phenotype: long-term evaluation of immunologic reconstitution after bone marrow transplantation..
97:880-885.
2001
-
Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency..
97:809-811.
2001
-
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial..
97:404-409.
2001
-
Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b..
97:376-382.
2001
-
Addition of stem cells from allogeneic donors accelerates engraftment and immune reconstitution after stem cell transplantation.
96.
2000
-
Adoptive immunotherapy with allogeneic EBV CTL for organ transplant patients with ebv induced lymphoproliferative disease.
96.
2000
-
Assay method, cord blood bank, nucleated cell count, and neonatal factors influence the CD34+ cell count in cord blood: The coblt experience.
96.
2000
-
Binding and activation of monocytes by pf4/heparin specific antibodies.
96.
2000
-
CD2-mediated IL-12-dependent signals render human gamma delta-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies..
96:3827-3837.
2000
-
Circulating pig-a mutant t lymphocytes in healthy adults and patients with bone marrow failure syndromes including pnh.
96.
2000
-
Combination treatment of bullous skin gvhd with ANTI-CD20 and ANTI-CD25 antibodies.
96.
2000
-
Cytokine regulation of inducffile nitric oxide synthase (nos2) and nos2 inhibitor-induced apoptosis and death in chronic lymphocytic leukemia cells.
96.
2000
-
Effect of age and replicative stress on hematopoietic stem cell telomere length.
96.
2000
-
Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model demonstrates the requirement for human platelet factor 4 and platelet activation through fcyriia.
96.
2000
-
High dose chemotherapy followed by transplantation of unrelated, banked, umbilical cord blood provides curative therapy for young pediatric patients with familial erythrophagocytic lymphohistiocytosis fed.
96.
2000
-
Human erythrocyte and endothelial cells contain tbs ce transglutaminase that can regulates inflammation a nd platelet function by binding and releasing nitric oxde.
96.
2000
-
Hyperhomocysteenemia induces alterations in fffirinogen function and fibrin clot structure in a rabbit model.
96.
2000
-
In vivo behavior of factor ix and certain gla domain mutants evaluated in coagulation factor k-deficient mice.
96.
2000
-
Inhibition of tyrosine kinase activity by sugen 5416 inhibits fibrin dependent angiogenesis.
96.
2000
-
Interchangeabelity of cytokine receptor signals during terminal myeloid differentiation: erythropoietin receptor (epor) signals support granulocytic differentiation and induction of myeloid gene expression.
96.
2000
-
Inverse relationship of plasma prostaglandin-E2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with plasmodium falciparum malaria.
96.
2000
-
Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model.
96.
2000
-
Nitric oxide asa nonprotein regulator of hematopoietic cell proliferation and differentiation-relationship to malarial anemia.
96.
2000
-
Novel nuclear target for thrombin: activation of the Elk1 transcription factor leads to chemokine gene expression..
96:3696-3706.
2000
-
Outcomes of unrelated umbilical cord blood transplantation in 158 pediatric patients consecutively transplanted at a single institution using cord blood units from a single bank.
96.
2000
-
Phase i trial of continuously infused gemcitabine with cpt-11 for refractory hematologic malignancies.
96.
2000
-
Preliminary characterization of the surface staining of placental derived adherent cells: a potential new source of stroma for umbilical cord blood (ucb) expansion.
96.
2000
-
Quantitative modelling to predict candidates for outpatient blood and/or marrow transplantation (BMT).
96.
2000
-
Relationship between transferrin saturation and iron stores in U.S. African-american and caucasian populations.
96.
2000
-
The Nramp2/DMT1 iron transporter is induced in the duodenum of microcytic anemia mk mice but is not properly targeted to the intestinal brush border..
96:3964-3970.
2000
-
Transplantation of adult and pediatric cancer patients with cord blood progenitors expanded ex vivo.
96.
2000
-
Unrelated umbilical cord blood transplant for osteopetrosis.
96.
2000
-
Assay method, cord blood bank, nucleated cell count, and neonatal factors influence the CD34+cell count in cord blood: The COBLT experience..
96:302B-302B.
2000
-
Banked umbilical cord blood is an excellent source of donor hematopoietic stem cells for infants with malignant and non-malignant conditions lacking a related donor..
96:587A-+.
2000
-
Binding and activation of monocytes by PF4/heparin specific antibodies..
96:269A-269A.
2000
-
Characterization of HLA polymorphism in an ethnically diverse cord blood bank..
96:301B-301B.
2000
-
Chimerism mediated immunotherapy using Campath T cell depleted peripheral blood progenitor cells (PBPC) with nonablative therapy provides reliable, durable allogeneic engraftment..
96:521A-521A.
2000
-
Cytokine regulation of inducible nitric oxide synthase (NOS2) and NOS2 inhibitor-induced apoptosis and death in chronic lymphocytic leukemia cells..
96:159A-159A.
2000
-
Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) after high-dose immunosuppressive therapy (HDIT) and autologous CD34-selected stem cell transplantation (SCT) for severe autoimmune diseases..
96:406A-406A.
2000
-
Expression of tumor suppressor genes IRF-1 and DAP-kinase in primitive AML cells..
96:696A-696A.
2000
-
Hematopoietic engraftment and survival after unrelated donor umbilical cord blood (UCB) transplantation in adult recipients..
96:587A-+.
2000
-
Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model demonstrates the requirement for human platelet factor 4 and platelet activation through Fc gamma RIIA..
96:221A-221A.
2000
-
High dose chemotherapy followed by transplantation of unrelated, banked, umbilical cord blood provides curative therapy for young pediatric patients with familial erythrophagocytic lymphohistiocytosis (FEL)..
96:362B-362B.
2000
-
High-dose immunosuppressive therapy (HDIT) and autologous stem cell transplant for severe systemic sclerosis (SSc)..
96:844A-844A.
2000
-
Human erythrocyte and endothelial cells contain tissue transglutaminase that can regulates inflammation and platelet function by binding and releasing nitric oxide..
96:38A-38A.
2000
-
In vivo behavior of factor IX and certain GLA domain mutants evaluated in coagulation factor M-deficient mice..
96:35A-35A.
2000
-
Induction of apoptosis in primitive human AML cells using the proteasome inhibitor MG-132 and/or sodium salicylate..
96:80A-80A.
2000
-
Inhibition of tyrosine kinase activity by SUGEN 5416 inhibits fibrin dependent angiogenesis..
96:57B-57B.
2000
-
Inverse relationship of plasma prostaglandin-E-2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with Plasmodium falciparum malaria..
96:31B-31B.
2000
-
Limitations of using CD23 expression by flow cytometry to differentiate mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma..
96:330A-330A.
2000
-
Low incidence of Epstein-Barr virus-associated post-transplant lymphoproliferative disorders (EBV-PTLD) in 263 unrelated donor umbilical cord blood transplant recipients..
96:206A-206A.
2000
-
Nitric oxide as a nonprotein regulator of hematopoietic cell proliferation and differentiation-relationship to malarial anemia..
96:14B-14B.
2000
-
Outcomes of unrelated umbilical cord blood transplantation in 158 pediatric patients consecutively transplanted at a single institution using cord blood units from a single bank..
96:206A-206A.
2000
-
Overexpression of anti-apoptosis genes in association with resistance to apoptosis observed in bone marrow failure syndromes..
96:526A-526A.
2000
-
Oxygen-dependent export of nitric oxide from red blood cells..
96:596A-+.
2000
-
Pediatric ALK-positive lymphomas coexpress c-Myc..
96:128A-128A.
2000
-
Phase I trial of continuously infused gemcitabine with CPT-11 for refractory hematologic malignancies..
96:216B-216B.
2000
-
Phase I trial of continuously infused gemcitabine with mitoxantrone for high risk or relapsed acute leukemia..
96:326A-326A.
2000
-
Phase I trial of escalting doses of 4-hydroxycyclophosphamide (4HC) purged autologous peripheral blood progenitor cells (PBPC) for leukemia..
96:385A-385A.
2000
-
Predictive value of day+50 immune reconstitution on the incidence of opportunistic infections and acute GVHD following unrelated cord blood transplants in children..
96:789A-789A.
2000
-
Preliminary characterization of the surface staining of placental derived adherent cells: A potential new source of stroma for umbilical cord blood (UCB) expansion..
96:150B-150B.
2000
-
Relationship between transferrin saturation and iron stores in US African-American and Caucasian populations..
96:226A-226A.
2000
-
Serum alpha-2 macroglobulin (alpha 2M) determines NAT binding capacity in patients with peripheral vascular disease (PVD)..
96:273A-273A.
2000
-
Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT)..
96:842A-843A.
2000
-
Umbilical cord blood graft engineering using bone marrow stroma to enhance hematopoietic stem and progenitor cell content..
96:774A-774A.
2000
-
Unrelated umbilical cord blood transplant for osteopetrosis..
96:207A-207A.
2000
-
Use of serum-free media to minimize apoptosis of chronic lymphocytic leukemia cells during in vitro culture..
96:754A-754A.
2000
-
A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment..
96:3499-3504.
2000
-
Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer..
96:3001-3007.
2000
-
Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cells..
96:2828-2833.
2000
-
A topological study of the human gamma-glutamyl carboxylase..
96:973-978.
2000
-
The molecular defect in hypotransferrinemic mice..
96:1113-1118.
2000
-
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies..
96:71-75.
2000
-
The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators..
95:3223-3231.
2000
-
Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases..
95:2913-2921.
2000
-
Potentiation of CD3-induced expression of the linker for activation of T cells (LAT) by the calcineurin inhibitors cyclosporin A and FK506..
95:2733-2741.
2000
-
X-linked genetic factors regulate hematopoietic stem-cell kinetics in females..
95:2449-2451.
2000
-
Impact of bone marrow transplantation for symptomatic sickle cell disease: An interim report.
95:1918-1924.
2000
-
Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease..
95:1918-1924.
2000
-
Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies..
95:1533-1540.
2000
-
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality..
95:1743-1751.
2000
-
Sustained expression of human factor VIII in mice using a parvovirus-based vector..
95:1594-1599.
2000
-
PG27, an extract of Tripterygium wilfordii hook f, induces antigen-specific tolerance in bone marrow transplantation in mice..
95:705-710.
2000
-
Prevalence of hepatitis c in adults with sickle cell disease.
96.
2000
-
Normal neutrophil function in cathepsin G-deficient mice..
94:4282-4293.
1999
-
The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha..
94:4233-4246.
1999
-
A Phase I study of 2-amino-9-B-D-arabinosyl-6-methoxy-9H-purine (506U78) administered on a consecutive five day schedule in children and adults with refractory hematologic malignancies..
94:629A-629A.
1999
-
Absolute lymphoid and myeloid dendritic cell counts in umbilical cord blood grafts and in recipients of unrelated umbilical cord blood transplants..
94:326B-326B.
1999
-
Acute lymphoblastic leukemia in infancy: Improved outcome with unrelated placental cord blood (PCB) transplants..
94:712A-712A.
1999
-
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo expaned cells, a phase I trial using the replicell system..
94:571A-571A.
1999
-
Cell cycle analyses and apoptosis in primitive leukemic and normal cells..
94:687A-687A.
1999
-
Characterization of a monoclonal antibody to PF4/heparin (KKO) with functional and serologic properties of hit antibodies..
94:21A-21A.
1999
-
Diffuse alveolar hemorrhage after hematopoietic stem cell transplantation for mucopolysaccharidosis type 6: Report of 3 cases..
94:334A-335A.
1999
-
Evaluation of thalidomide for the treatment of chronic graft-versus-host disease in "high risk" patients..
94:158A-158A.
1999
-
Human platelet adducin: A regulated actin filament barbed end-capping protein..
94:216A-216A.
1999
-
Inducible nitric oxide synthase (NOS2) inhibitors induce high level CLL cell apoptosis and death..
94:703A-703A.
1999
-
Laminin binding and B-CAM/LU expression by high and low density reticulocytes vs mature red cells in sickle cell disease..
94:675A-675A.
1999
-
Manipulation of CD22 signal transduction for the treatment of lymphoma..
94:93A-93A.
1999
-
Markers of angiogenesis, factor VIII and tenascin, correlate with disease activity in patients with Non-Hodgkin's Lymphoma..
94:253B-253B.
1999
-
Stable mixed chimerism after bone marrow transplantation (BMT) for Sickle Cell Disease (SCD)..
94:645A-645A.
1999
-
Stroma from adult bone marrow increases the productivity of ex vivo cord blood expansion cultures..
94:164B-164B.
1999
-
The effect of cytokine combinations on the clinical scale ex-vivo expansion of umbilical cord blood..
94:573A-573A.
1999
-
The interleukin-3 receptor alpha chain is highly expressed on primitive acute myelogenous leukemia cells..
94:67A-67A.
1999
-
Transplantation of a patient with congenital neutropenia and invasive fungal disease with unrelated umbilical cord blood using paternal G-CSF mobilized, irradiated granulocyte support..
94:368B-369B.
1999
-
Unrelated umbilical cord blood transplants in adult patients (pts) with hematologic malignancies or genetic disorders..
94:570A-570A.
1999
-
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study..
94:2208-2216.
1999
-
CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK/SAPK signaling cascade..
94:1382-1392.
1999
-
Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone..
94:340-347.
1999
-
The C282Y mutation causing hereditary hemochromatosis does not produce a null allele..
94:9-11.
1999
-
Cirrhosis of the liver in long-term marrow transplant survivors..
93:3259-3266.
1999
-
Rapid telomere shortening in children..
93:2824-2830.
1999
-
A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients..
93:2491-2501.
1999
-
Optimal proliferation of a hematopoietic progenitor cell line requires either costimulation with stem cell factor or increase of receptor expression that can be replaced by overexpression of Bcl-2..
93:2569-2577.
1999
-
Comparison of immune reconstitution after unrelated and related T-cell- depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions.
93:467-480.
1999
-
DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1..
93:399-409.
1999
-
Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1..
92:4677-4690.
1998
-
A phase I trial of augmentation of unrelated umbilical cord blood transplantation with ex-vivo expanded cells..
92:646A-646A.
1998
-
Busulfan and melphalan as preparative therapy for BMT in childhood leukemias..
92:128A-128A.
1998
-
Detection of inducible nitric oxide synthase (NOS2) mRNA, antigen and enzyme activity in leukemia cells from patients with CLL..
92:431A-431A.
1998
-
Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow..
92:3780-3792.
1998
-
Enhanced fludarabine cytotoxicity in B-CLL lymphocytes by combination with nitric oxide donors or doxorubicin..
92:596A-596A.
1998
-
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53..
92:3804-3816.
1998
-
Long term disease free survival for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high dose therapy with hematopoietic support..
92:323A-323A.
1998
-
Mechanisms of resistance to apoptosis in granulocytes of patients with paroxysmal nocturnal hemoglobinuria..
92:6B-7B.
1998
-
Nitric oxide modulates extracellular matrix stabilization by inhibiting endothelial cell transglutaminase activity..
92:77B-77B.
1998
-
Prognostic factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high dose therapy with hematopoietic support..
92:462A-463A.
1998
-
Transient engraftment of maternal T-cells in recipients of unrelated cord blood transplants..
92:652A-653A.
1998
-
Transplantation of related, haplo-identical umbilical cord blood in pediatric patients with genetic hematological diseases..
92:358B-358B.
1998
-
Unrelated cord blood transplantation for correction of genetic diseases..
92:291A-291A.
1998
-
Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia..
92:3250-3259.
1998
-
Evidence for genetic homogeneity in a familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML).
92:2600-2602.
1998
-
Role of JAK3 in CD40-mediated signaling..
92:2435-2440.
1998
-
The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria..
92:2541-2550.
1998
-
Iron is hot: an update on the pathophysiology of hemochromatosis..
92:1845-1851.
1998
-
The G185R mutation disrupts function of the iron transporter Nramp2..
92:2157-2163.
1998
-
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111..
92:1556-1564.
1998
-
Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia..
92:1455-1456.
1998
-
The distal cytoplasmic domain of the erythropoietin receptor induces granulocytic differentiation in 32D cells..
92:1219-1224.
1998
-
Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase..
92:394-401.
1998
-
Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations..
91:4188-4196.
1998
-
Long-term outcome after marrow transplantation for severe aplastic anemia..
91:3637-3645.
1998
-
Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors..
91:3182-3192.
1998
-
Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children.
91:2601-2608.
1998
-
Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group..
91:2601-2608.
1998
-
Distribution of transferrin saturations in the African-American population..
91:2175-2179.
1998
-
Gamma-globin gene promoter elements required for interaction with globin enhancers..
91:309-318.
1998
-
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease..
90:4705-4709.
1997
-
A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy..
90:4313-4320.
1997
-
Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study..
90:4532-4538.
1997
-
Acquired DNA mutations in adults with myeloproliferative disorders receiving hydroxyurea therapy..
90:1542-1542.
1997
-
B-CAM/LU protein: A single IgSF domain and copy number but not the cytoplasmic region are critical for laminin binding..
90:2685-2685.
1997
-
Clinical-scale expansion of human umbilical cord blood cells in an automated perfused culture system..
90:4283-4283.
1997
-
Correction of beta thalassemia major with umbilical cord blood transplantation from a related haploidentical donor..
90:4536-4536.
1997
-
Ex vivo expansion and retroviral vector transduction of umbilical cord food (UCB) platelet progenitors..
90:2392-2392.
1997
-
Extrathymic stem cells develop into dendritic cells in human thymic microenvironments in vitro..
90:3382-3382.
1997
-
Hematopoietic recovery in adult recipients following unrelated umbilical cord blood (UCB) transplantation..
90:480-480.
1997
-
Immune recovery post unrelated allogeneic umbilical cord blood (UCB) transplantation in adult recipients..
90:1868-1868.
1997
-
Inhibitor development after surgical exposure to bovine thrombin: Antibody spectrum and clinical outcomes..
90:2083-2083.
1997
-
Marked of cytotoxicity of SN-38 and novel camptothecin derivatives to chronic B-cell lymphocytic leukemia lymphocytes in vitro..
90:2371-2371.
1997
-
Marked radiographic improvement in infantile hypophosphatasia with T-depleted bone marrow transplantation from a related haploidentical donor..
90:4537-4537.
1997
-
The transglutaminase enzyme derived from vascular cells contributes to the proangiogenic properties of fibrin..
90:3043-3043.
1997
-
Transplantation of unrelated donor umbilical cord blood (UCB): Outcomes and analysis of risk factors..
90:1767-1767.
1997
-
Unrelated donor stem cell transplant for Fanconi anemia: Multicenter report of forty-nine cases.
90:474-474.
1997
-
Unrelated placental cord blood transplantation in a patient with sickle cell disease and acute non-lymphocytic leukemia..
90:4542-4542.
1997
-
Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients..
90:2939-2951.
1997
-
Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapy..
90:2406-2416.
1997
-
Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients..
90:2196-2206.
1997
-
Soluble monomeric P-selectin containing only the lectin and epidermal growth factor domains binds to P-selectin glycoprotein ligand-1 on leukocytes..
90:2381-2389.
1997
-
Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia..
90:1410-1414.
1997
-
T helper 2-dominant antilymphoma immune response is associated with fatal outcome..
90:1611-1617.
1997
-
Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene..
89:4628-4635.
1997
-
Human MafG is a functional partner for p45 NF-E2 in activating globin gene expression..
89:3925-3935.
1997
-
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose..
89:4226-4235.
1997
-
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial..
89:3880-3887.
1997
-
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin..
89:3890-3891.
1997
-
Receptors that induce erythroid differentiation of Ba/F3 cells: structural requirements and effect on STAT5 binding..
89:3175-3185.
1997
-
Adenosine deaminase deficiency in adults..
89:2849-2855.
1997
-
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation..
89:3055-3060.
1997
-
Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency..
89:1968-1977.
1997
-
Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graft-versus-host disease..
89:1452-1459.
1997
-
Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022..
89:780-788.
1997
-
High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices..
89:801-813.
1997
-
Fc gamma RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis..
89:370-375.
1997
-
FcγRIIA H/R131
polymorphism, subclass-specific IgG anti- heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis.
89:370-375.
1997
-
2-amino-9-B-D-arabinosyl-6-methoxy-9H-guanine (GW 506U; compound 506U) is highly active in patients with T-cell malignancies: Results of a phase I trial in pediatric and adult patients with refractory hematological malignancies..
88:2666-2666.
1996
-
A conserved element in the human CD7 promoter binds dbpA and a novel zinc finger protein..
88:770-770.
1996
-
AXL receptor tyrosine kinase mediates ligand dependent cell adhesion and is expressed in mature bone marrow monocytes..
88:2130-2130.
1996
-
Acute profound thrombocytopenia following C7E3 FAB (abciximab) therapy..
88:2055-2055.
1996
-
BCAM/LU protein: A novel laminin receptor overexpressed by sickle erythrocytes.
88:13-13.
1996
-
Characterization of K12, a novel molecule with potential growth promoting activity produced by granulocytes.
88:65-65.
1996
-
Gamma globin promoter elements required for interaction with globin enhancers..
88:595-595.
1996
-
Growth factor modulation of p21(WAF1/CIP1) in primary acute myeloid leukemias..
88:331-331.
1996
-
Hematopoietic engraftment using placental cord blood (PCB) unrelated donor transplantation in recipients >40 kg weight..
88:1051-1051.
1996
-
Increased prevalence of Kaposi's sarcoma-associated herpesvirus in peripheral blood mononuclear cells of HIV-infected homosexuals..
88:1992-1992.
1996
-
Multiparameter fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells..
88:1727-1727.
1996
-
New York blood center's program for unrelated placental umbilical cord blood (PCB) transplantation: 243 transplants in the first 3 years..
88:557-557.
1996
-
PE-2 (ERF), a novel ETS factor, is hypophosphorylated in c-kit(+) K562 cells..
88:3183-3183.
1996
-
Pharmacokinetics of arabinosylguanine (ara-G) and its triphosphate (ara-GTP) during a phase I trial of compound GW506U in refractory hematologic malignancies: Correlation with response..
88:2667-2667.
1996
-
Report on patients with glycogen storage disease 1b with severe chronic neutropenia (SCN) treated with filgrastim..
88:1383-1383.
1996
-
Schedule dependent growth inhibition and induction of apoptosis by nitric oxide in leukemia cells..
88:269-269.
1996
-
FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors..
88:3634-3641.
1996
-
P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells..
88:3010-3021.
1996
-
Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia..
88:2473-2479.
1996
-
Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine..
88:2354-2355.
1996
-
Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU..
88:1649-1655.
1996
-
Nitric oxide interactions with cobalamins: biochemical and functional consequences..
88:1857-1864.
1996
-
p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells..
88:1551-1560.
1996
-
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation..
88:824-830.
1996
-
Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation..
87:4723-4730.
1996
-
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy..
87:3607-3614.
1996
-
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation..
87:3045-3052.
1996
-
Differential effects of nitric oxide on erythroid and myeloid colony growth from CD34+ human bone marrow cells..
87:977-982.
1996
-
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors..
87:51-58.
1996
-
Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients..
87:386-392.
1996
-
A novel insert at the 5' end of the human inducible nitric oxide synthase gene..
86:115-115.
1995
-
Compound 506 (2-amino-6-methoxypurine arabinoside) is active against resistant T-cell malignancies: Preliminary results of a Phase I trial prior to definition of a MTD..
86:2034-2034.
1995
-
DNA damage induced apoptosis by p53-mediated activation of p34(cdc2) kinase..
86:1714-1714.
1995
-
Ectopic and elevated expression of a novel receptor tyrosine kinase C-MER, may distinguish a subset of childhood T cell acute lymphatic leukemias..
86:3029-3029.
1995
-
Erythroid progenitors express a CD44 variant with reduced hyaluronic acid binding ability and reduced expression of the epitope associated with Hemophilus influenzae hemagglutination.
86:1876-1876.
1995
-
Flow cytometric detection of gene transfer into progenitor cells from cryopreserved umbilical cord blood (UCB)..
86:937-937.
1995
-
Inhibition of HIV-1 integrase by hydroxocobalamin.
86:2231-2231.
1995
-
Isolation and characterization of a novel ETS factor, PE-2..
86:2632-2632.
1995
-
Modulation of hyaluronan binding to CD44H..
86:1877-1877.
1995
-
Nitric oxide and cobalamins: NO-Cb1 interactions with light, oxygen, hemoglobin, and glutathione..
86:494-494.
1995
-
Structure of the mouse CD83 gene.
86:1280-1280.
1995
-
T cell lymphoblastic leukemia with mediastinal mass and c-kit expression..
86:3095-3095.
1995
-
The hematopoietic defect in paroxysmal nocturnal hemoglobinuria assessed by long-term bone marrow culture..
86:511-511.
1995
-
The oncogenic E2A-HLF fusion protein protects leukemic B-precursor cells from apoptosis..
86:1297-1297.
1995
-
Umbilical cord blood: An alternative source of hemopoietic stem cells for bone marrow reconstitution in unrelated donor transplantation..
86:1147-1147.
1995
-
Vascular localization of the heparin-binding serpins antithrombin, heparin cofactor II and protein C inhibitor..
86:1493-1493.
1995
-
A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells..
86:3295-3301.
1995
-
Rolling in P-selectin-deficient mice is reduced but not eliminated in the dorsal skin..
86:3487-3492.
1995
-
Thalidomide as salvage therapy for chronic graft-versus-host disease..
86:3604-3609.
1995
-
Unrelated donor marrow transplantation in children..
86:3247-3256.
1995
-
A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia..
86:2028-2032.
1995
-
Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation..
86:1794-1801.
1995
-
Prevalence of heterozygotes for hemochromatosis in the white population of the United States..
86:2021-2027.
1995
-
Inhibition of productive human immunodeficiency virus-1 infection by cobalamins..
86:1281-1287.
1995
-
Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages..
86:1184-1195.
1995
-
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study..
85:3746-3753.
1995
-
Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia..
85:3353-3354.
1995
-
Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma..
85:3334-3341.
1995
-
Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients..
85:2632-2638.
1995
-
Telomerase activity in normal leukocytes and in hematologic malignancies..
85:2315-2320.
1995
-
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and leukemia group B study 8811.
85:2025-2037.
1995
-
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811..
85:2025-2037.
1995
-
Neurologic complications after allogeneic marrow transplantation for sickle cell anemia..
85:879-884.
1995
-
Erythrocyte blood group antigens: not so simple after all..
85:299-306.
1995
-
Lectin and epidermal growth factor domains of P-selectin at physiologic density are the recognition unit for leukocyte binding..
85:151-158.
1995
-
Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia..
84:4368-4373.
1994
-
CHARACTERIZATION OF A NOVEL ECTO-ADP-RIBOSYL-TRANSFERASE IN T-LYMPHOCYTES BY THE B-SUBUNIT OF PERTUSSIS TOXIN.
84:A432-A432.
1994
-
COBALAMINS AND AIDS - POTENT INHIBITION OF HIV-1 INFECTION OF HUMAN MONOCYTES, PERITONEAL-MACROPHAGES, AND BLOOD MONONUCLEAR-CELLS IN-VITRO BY HYDROXOCOBALAMIN, METHYLCOBALAMIN, OR ADENOSYLCOBALAMIN.
84:A480-A480.
1994
-
DEOXYCOFORMYCIN IS ACTIVE AGAINST LANGERHANS CELL HISTIOCYTOSIS.
84:A596-A596.
1994
-
EVIDENCE THAT CDW108 MEMBRANE-PROTEIN BEARS THE JMH BLOOD-GROUP ANTIGEN.
84:A237-A237.
1994
-
G-CSF-PRIMED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) COLLECTED IN THE STEADY-STATE ARE SUPERIOR TO G-CSF-PRIMED PBPCS COLLECTED ON THE REBOUND FROM CHEMOTHERAPY.
84:A107-A107.
1994
-
NITRIC-OXIDE COBALAMIN INTERACTIONS - IMPLICATIONS REGARDING VITAMIN-B12 DEFICIENCY STATES.
84:A118-A118.
1994
-
NITRIC-OXIDE INHIBITS THE GROWTH OF HUMAN BONE-MARROW COLONIES BY A DIRECT EFFECT ON CD34+ CELLS.
84:A268-A268.
1994
-
PHASE-I CONCENTRATION-CONTROLLED, ESCALATION TRIAL OF LISOFYLLINE (LSF) IN PATIENTS (PTS) UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT).
84:A89-A89.
1994
-
SECONDARY T-CELL DEPLETED (TCD) MARROW BOOST FOR DELAYED IMMUNE RECOVERY FOLLOWING T-DEPLETED BONE-MARROW TRANSPLANTATION (BMT).
84:A491-A491.
1994
-
SUCCESSFUL TREATMENT (RX) OF PATIENTS (PTS) WITH REFRACTORY SEVERE APLASTIC-ANEMIA (SAA) WITH CONCOMITANT CYCLOSPORINE (CSA) AND COLONY-STIMULATING FACTORS (CSF).
84:A10-A10.
1994
-
THE CD45 TYROSINE PROTEIN-KINASE IS NOT REQUIRED FOR SIGNALING AND ACTIVATION OF HUMAN T-LYMPHOCYTES BY THE PERTUSSIS TOXIN RECEPTOR.
84:A285-A285.
1994
-
THE PATHOGENESIS OF INTERLEUKIN-2 CYTOTOXICITY TO HUMAN STEM-CELL LEUKEMIA IN SCID MICE.
84:A47-A47.
1994
-
Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology..
84:3205-3211.
1994
-
Prevention of graft-versus-host disease by peptides binding to class II major histocompatibility complex molecules..
84:2802-2810.
1994
-
Inhibition of leukocyte L-selectin function with a monoclonal antibody attenuates reperfusion injury to the rabbit ear..
84:2322-2328.
1994
-
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide..
84:2036-2043.
1994
-
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
84:1672-1679.
1994
-
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase..
84:1672-1679.
1994
-
Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation..
84:1680-1684.
1994
-
The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen..
84:1402-1407.
1994
-
Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes..
84:1276-1282.
1994
-
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor..
84:1320-1327.
1994
-
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.
84:941-949.
1994
-
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia..
84:941-949.
1994
-
ACTIVATION OF FACTOR-X BY FACTOR VIIA ON MONOCYTE CELL-SURFACES.
83:3828-3828.
1994
-
Activation of factor X by factor VIIa on monocyte cell surfaces..
83:3828-3829.
1994
-
Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support..
83:3132-3137.
1994
-
Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors..
83:3417-3418.
1994
-
A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation..
83:2823-2828.
1994
-
Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting..
83:2851-2859.
1994
-
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia..
83:2749-2750.
1994
-
High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma..
83:1903-1908.
1994
-
The cell and molecular basis of leukocyte common antigen (CD45)-triggered, lymphocyte function-associated antigen-1-/intercellular adhesion molecule-1-dependent, leukocyte adhesion..
83:1862-1870.
1994
-
Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity..
83:1595-1602.
1994
-
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia..
83:1603-1611.
1994
-
A novel beta-globin mutation, beta Durham-NC [beta 114 Leu-->Pro], produces a dominant thalassemia-like phenotype..
83:1109-1116.
1994
-
CD antigens 1993..
83:879-880.
1994
-
Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step..
83:816-821.
1994
-
Release of tumor cells from bone marrow..
83:623-625.
1994
-
Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia..
83:38-42.
1994
-
A SINGLE 6-HOUR (HR) STEADY-STATE LEUKAPHERESIS IS SUFFICIENT FOR COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AFTER G-CSF.
82:A349-A349.
1993
-
COMPUTER IMAGING OF BETA-DURHAM-NC [BETA(114) LEU-]PRO], A THALASSEMIC HEMOGLOBINOPATHY.
82:A358-A358.
1993
-
EFFECT OF NITRIC-OXIDE (NO) ON THE GROWTH AND DIFFERENTIATION OF FRESHLY ISOLATED ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL) CELLS.
82:A491-A491.
1993
-
EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) EXPRESSED IN CHINESE-HAMSTER OVARY CELLS (CHO-GM), ESCHERICHIA-COLI (E-COLI-GM) OR YEAST (YEAST-GM) ON PRIMING PERIPHERAL-BLOOD PROGENITOR CELLS FOR USE WITH AUTOLOGOUS BONE-MARROW AFTER HIGH-DOSE CHEMOTHERAPY.
82:A293-A293.
1993
-
EXPRESSION OF C-KIT RECEPTORS AND KIT-LIGAND IN HUMAN THYMOCYTES AND THYMUS TISSUE.
82:A244-A244.
1993
-
HAPLOIDENTICAL TRANSPLANTATION OF UMBILICAL-CORD BLOOD MONONUCLEAR-CELLS IN A PEDIATRIC-PATIENT WITH AML.
82:A634-A634.
1993
-
HUMAN MONONUCLEAR PHAGOCYTE NITRIC-OXIDE SYNTHASE (NOS) - EVIDENCE FOR INDUCTION OF NOS MESSENGER-RNA AND PROTEIN WITHOUT DETECTABLE CAPACITY FOR NITRIC-OXIDE PRODUCTION.
82:A186-A186.
1993
-
INVESTIGATION OF THE HOLLEY GREGORY DOMBROCK BLOOD-GROUP ANTIGEN PROTEIN USING A NOVEL MONOCLONAL-ANTIBODY.
82:A267-A267.
1993
-
LOCALIZATION OF THE GENE FOR INDUCIBLE NITRIC-OXIDE SYNTHASE TO DISTAL MOUSE CHROMOSOME-11 - RELEVANCE TO INFLAMMATION, ARTHRITIS, DIABETES-MELLITUS, AND AUTOIMMUNITY.
82:A29-A29.
1993
-
MONOCYTE CHEMOATTRACTANT ACTIVITY OF ACTIVE-SITE MUTANT RECOMBINANT THROMBIN AND THROMBIN RECEPTOR PEPTIDE SFLLRN.
82:A26-A26.
1993
-
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583..
82:2975-2984.
1993
-
REGULATION OF ALTERNATIVELY SPLICED CD45 MESSENGER-RNA TRANSCRIPTS DURING T-CELL MATURATION.
82:A244-A244.
1993
-
SYNOVIAL LINING MACROPHAGES IN RHEUMATOID-ARTHRITIS PREFERENTIALLY EXPRESS SPECIFIC CD44-VARIANT ISOFORMS COMPARED TO OTHER TISSUE MACROPHAGES.
82:A32-A32.
1993
-
THE CD3-T CELL ANTIGEN RECEPTOR COMPLEX REGULATES PERTUSSIS TOXIN RECEPTOR-STIMULATED TYROSINE PROTEIN-PHOSPHORYLATION.
82:A246-A246.
1993
-
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission..
82:2920-2928.
1993
-
L-selectin can mediate leukocyte rolling in untreated mesenteric venules in vivo independent of E- or P-selectin..
82:1632-1638.
1993
-
Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria..
82:1192-1196.
1993
-
Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome..
82:677-681.
1993
-
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia..
81:2496-2502.
1993
-
Characterization of the DNase I hypersensitive site 3' of the human beta globin gene domain..
81:2781-2790.
1993
-
Volume and osmotic properties of human neutrophils..
81:2774-2780.
1993
-
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy..
81:2031-2035.
1993
-
Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy..
81:1709-1719.
1993
-
Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor..
81:1787-1791.
1993
-
Risk factors for acute graft-versus-host disease associated with cyclosporine and methotrexate prophylaxis..
81:1972-1974.
1993
-
Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus..
81:1290-1299.
1993
-
Interleukin-3 expression by activated T cells involves an inducible, T-cell-specific factor and an octamer binding protein..
81:928-934.
1993
-
Degradation of von Willebrand factor in patients with acquired clinical conditions in which there is heightened proteolysis..
81:720-725.
1993
-
Human erythrocyte acetylcholinesterase bears the Yta blood group antigen and is reduced or absent in the Yt(a-b-) phenotype..
81:815-819.
1993
-
Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia..
81:319-323.
1993
-
Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus..
81:249-253.
1993
-
Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients..
80:2128-2135.
1992
-
Nitric oxide modulation of human leukemia cell differentiation and gene expression..
80:1880-1884.
1992
-
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate..
80:1838-1845.
1992
-
Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency..
80:1163-1171.
1992
-
Enhanced expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor receptor subunits in murine hematopoietic cells stimulated with hematopoietic growth factors..
80:1183-1189.
1992
-
Dynamic assessment of quality of life after autologous bone marrow transplantation..
80:825-830.
1992
-
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia..
80:560-561.
1992
-
Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: dissociation of acivicin-induced TNF-alpha and IL-1 beta mRNA expression from acivicin-induced monocytoid differentiation..
79:3337-3343.
1992
-
Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia..
79:3091-3092.
1992
-
Hydroxyurea: specific therapy for sickle cell anemia?.
79:2503-2506.
1992
-
Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone..
79:2566-2571.
1992
-
Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors..
79:2572-2577.
1992
-
Isolation of the JMH antigen on a novel phosphatidylinositol-linked human membrane protein..
79:1574-1581.
1992
-
Cardiopulmonary bypass induces leukocyte-platelet adhesion..
79:1201-1205.
1992
-
Spontaneous delta- to beta-globin switching in K562 human leukemia cells..
79:820-825.
1992
-
Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation..
79:517-526.
1992
-
Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone..
79:289-291.
1992
-
Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction..
79:38-44.
1992
-
A randomized comparison of two doses of human lymphoblastoid interferon-alpha in hairy cell leukemia. Wellcome HCL Study Group..
78:3133-3141.
1991
-
Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages..
78:3128-3132.
1991
-
The promoter of human T-cell leukemia virus type-I is repressed by the immediate-early gene region of human cytomegalovirus in primary blood lymphocytes..
78:2956-2961.
1991
-
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission..
78:1923-1927.
1991
-
Adducin in erythrocyte precursor cells of rats and humans: expression and compartmentalization..
78:1692-1696.
1991
-
A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer..
78:1420-1427.
1991
-
Molecular basis for elliptocytosis associated with glycophorin C and D deficiency in the Leach phenotype..
78:1603-1606.
1991
-
Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts..
78:1144-1145.
1991
-
Hepatitis C infection in children with hemophilia A and B..
78:285-289.
1991
-
Peritoneal fluid and plasma levels of human macrophage colony-stimulating factor in relation to peritoneal fluid macrophage content..
78:513-516.
1991
-
Purification and partial characterization of a human hematopoietic precursor population..
77:2122-2128.
1991
-
A combined approach for purging multidrug-resistant leukemic cell lines in bone marrow using a monoclonal antibody and chemotherapy..
77:2079-2084.
1991
-
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens..
77:1660-1665.
1991
-
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination..
77:1829-1836.
1991
-
Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells..
77:1681-1690.
1991
-
Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors..
77:1111-1117.
1991
-
Isolation and characterization of an acquired antithrombin antibody..
76:2249-2257.
1990
-
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens..
76:1867-1871.
1990
-
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment..
76:1464-1472.
1990
-
CEPP(B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma..
76:1293-1298.
1990
-
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?.
76:1037-1045.
1990
-
Relationship of the human erythrocyte Wrb antigen to an interaction between glycophorin A and band 3..
76:842-848.
1990
-
Catabolism of streptokinase and polyethylene glycol-streptokinase: evidence for transport of intact forms through the biliary system in the mouse..
76:73-79.
1990
-
Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation..
76:228-234.
1990
-
Long- and short-lived murine hematopoietic stem cell clones individually identified with retroviral integration markers..
75:2267-2270.
1990
-
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells..
75:1947-1950.
1990
-
Correlation between erythrocyte CR1 reduction and other blood proteinase markers in patients with malignant and inflammatory disorders..
75:1699-1704.
1990
-
Evidence that several high-frequency human blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins..
75:1404-1407.
1990
-
Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study..
75:166-173.
1990
-
Granulocyte-macrophage colony-stimulating factor and interleukin-3 mRNAs are produced by a small fraction of blood mononuclear cells..
74:1525-1530.
1989
-
Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin..
74:1728-1737.
1989
-
Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells..
74:1517-1524.
1989
-
Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model..
74:547-550.
1989
-
The Inab phenotype: characterization of the membrane protein and complement regulatory defect..
74:437-441.
1989
-
Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes..
73:2128-2132.
1989
-
Expression of protooncogene c-myb in normal human hematopoietic cells..
73:1444-1451.
1989
-
Heparin cofactor II-proteinase reaction products exhibit neutrophil chemoattractant activity..
73:1682-1685.
1989
-
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia..
73:1720-1728.
1989
-
Essential amino acid deprivation induces monocytic differentiation of the human HL-60 myeloid leukemia cell line..
73:1298-1306.
1989
-
Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines..
73:945-951.
1989
-
Graft-v-host disease is associated with autoimmune-like thrombocytopenia..
73:1054-1058.
1989
-
CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells..
73:381-390.
1989
-
Characterization of the serum In(Lu)-related antigen: identification of a serum protein related to erythrocyte p80..
73:596-600.
1989
-
Age as a prognostic factor in multiple myeloma..
73:353.
1989
-
A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases..
72:1861-1869.
1988
-
Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group Study..
72:1891-1897.
1988
-
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration..
72:1978-1984.
1988
-
Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino-terminal proteolytic cleavage..
72:1790-1796.
1988
-
Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans..
72:1310-1315.
1988
-
Donor buffy coat cell infusion after marrow transplantation for aplastic anemia..
72:1099-1100.
1988
-
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease..
72:555-561.
1988
-
Evidence that calpains and elastase do not produce the von Willebrand factor fragments present in normal plasma and IIA von Willebrand disease..
72:721-727.
1988
-
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation..
72:546-554.
1988
-
Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes..
72:128-133.
1988
-
Preparation of polyethylene glycol-tissue plasminogen activator adducts that retain functional activity: characteristics and behavior in three animal species..
71:1641-1647.
1988
-
The role of endothelium in factor Xa regulation: the effect of plasma proteinase inhibitors and hirudin..
71:1321-1328.
1988
-
Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia..
71:1144-1146.
1988
-
Cooperative effect of tumor necrosis factor and gamma-interferon on chemotactic peptide receptor expression and stimulus-induced actin polymerization in HL-60 cells..
71:1062-1067.
1988
-
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials..
71:293-298.
1988
-
Further characterization of erythrocyte p80 and the membrane protein defect of In(Lu) Lu(a-b-) erythrocytes..
70:1475-1481.
1987
-
Receptor-mediated monocytoid differentiation of human promyelocytic cells by tumor necrosis factor: synergistic actions with interferon-gamma and 1,25-dihydroxyvitamin D3..
70:994-1002.
1987
-
Identification of normal human peripheral blood monocytes and liver as sites of synthesis of coagulation factor XIII a-chain..
70:579-582.
1987
-
Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia..
70:247-253.
1987
-
Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals..
70:173-176.
1987
-
Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin..
70:116-121.
1987
-
Immune lymphocyte survival after chemotherapy and radiation..
69:1269.
1987
-
Antibodies to granulocyte precursors in selective myeloid hypoplasia and other suspected autoimmune neutropenias: use of HL-60 cells as targets..
69:529-536.
1987
-
Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors..
68:1363-1368.
1986
-
Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome..
68:1213-1217.
1986
-
Growth and development following marrow transplantation for leukemia..
68:1129-1135.
1986
-
Dibutyryl cyclic adenosine monophosphate reduces expression of c-myc during HL-60 differentiation..
68:412-416.
1986
-
Characterization of murine peritoneal macrophage receptors for fibrin(ogen) degradation products..
67:1224-1228.
1986
-
Chemoattractant-mediated stimulation of the respiratory burst in human polymorphonuclear leukocytes may require appearance of protein kinase activity in the cells' particulate fraction..
67:909-913.
1986
-
Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation..
67:1172-1175.
1986
-
Separation of the acetylcholinesterase-deficient red cells in paroxysmal nocturnal hemoglobinuria..
67:893-897.
1986
-
Bone marrow transplantation in patients aged 45 years and older..
67:770-776.
1986
-
Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group Study..
67:135-140.
1986
-
Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration..
67:203-206.
1986
-
Phenotypic characterization of gamma interferon-induced human monocyte polykaryons..
66:1241-1246.
1985
-
The acetylcholinesterase defect in paroxysmal nocturnal hemoglobinuria: evidence that the enzyme is absent from the cell membrane..
66:940-945.
1985
-
Antibody against T lymphoblastic leukemia-associated antigen (3-40) identifies vimentin and keratin intermediate filaments in normal cells..
66:642-648.
1985
-
Monoclonal antibody definition of T cell acute leukemia: a Pediatric Oncology Group study..
65:785-788.
1985
-
Catabolism of human tissue plasminogen activator in mice..
65:539-544.
1985
-
Human erythrocyte antigens: II. The In(Lu) gene regulates expression of an antigen on an 80-kilodalton protein of human erythrocytes..
64:599-606.
1984
-
Light scattering by polymorphonuclear leukocytes stimulated to aggregate under various pharmacologic conditions..
64:649-655.
1984
-
Marrow harvesting from normal donors..
64:630-634.
1984
-
Characterization of an oligopeptide chemoattractant receptor on human blood monocytes using a new radioligand..
63:588-592.
1984
-
Comparison of two long-term chemotherapy regimens, with or without agents to modify skeletal repair, in multiple myeloma..
63:639-648.
1984
-
Specific receptors for phorbol diesters on freshly isolated human myeloid and lymphoid leukemia cells: comparable binding characteristics despite different cellular responses..
63:298-304.
1984
-
Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients..
62:51-61.
1983
-
Human neutrophil dysfunction with giant granules and defective activation of the respiratory burst..
61:1247-1257.
1983
-
Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse..
61:949-953.
1983
-
Fanconi's anemia treated by allogeneic marrow transplantation..
61:954-959.
1983
-
Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?.
61:672-675.
1983
-
Studies of T-lymphocytes in preleukemic disorders and acute nonlymphocytic leukemia: in vitro radiosensitivity, mitogenic responsiveness, colony formation, and enumeration of lymphocytic subpopulations..
61:449-455.
1983
-
Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (a Pediatric Oncology Group Study)..
60:1159-1168.
1982
-
Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia..
60:856-863.
1982
-
Analysis of T-cell differentiation antigens in acute lymphatic leukemia using monoclonal antibodies..
60:752-757.
1982
-
Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease..
60:714-720.
1982
-
Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates..
60:463-473.
1982
-
Conditions for an in vitro culture of murine mixed hematopoietic colonies and their putative cellular origin..
60:99-107.
1982
-
Increased heat sensitivity of red blood cells in hereditary elliptocytosis with acquired cobalamin (vitamin B12) deficiency..
59:1213-1219.
1982
-
Low serum thymic hormone levels in patients with chronic graft-versus-host disease..
59:1073-1077.
1982
-
Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients..
59:236-246.
1982
-
Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease..
59:198-201.
1982
-
Phenotypic characterization of human bone marrow granulocyte-macrophage forming progenitor cells..
58:1047-1049.
1981
-
Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment..
58:360-368.
1981
-
An analysis of clinical and laboratory features of acute lymphocytic leukemias with emphasis on 35 children with pre-B leukemia..
58:135-140.
1981
-
The significance of splenomegaly in 101 adults with acute lymphoblastic leukemia (ALL) at presentation and during remission..
57:798-801.
1981
-
A radioreceptor assay for quantitating plasma factor VIII/von Willebrand's protein..
57:579-585.
1981
-
Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems..
57:510-517.
1981
-
Effects of quercetin on magnesium-dependent adenosine triphosphatase and the metabolism of human polymorphonuclear leukocytes..
57:561-566.
1981
-
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression..
57:267-276.
1981
-
Plasma thrombopoietic activity in humans with normal and abnormal platelet counts..
56:183-188.
1980
-
Complement sensitivity of paroxysmal nocturnal hemoglobinuria bone marrow cells..
55:1040-1046.
1980
-
Therapy of myeloma..
55:1070-1071.
1980
-
Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma..
54:824-836.
1979
-
Is there a precursive, relatively procoagulant-inactive form of normal antihemophilic factor (factor VIII)?.
54:916-927.
1979
-
Leukopheresis therapy of leukemic reticuloendotheliosis (hairy cell leukemia)..
54:747-749.
1979
-
Stimulation of neutrophil oxidative metabolism by chemotactic peptides: influence of calcium ion concentration and cytochalasin B and comparison with stimulation by phorbol myristate acetate..
54:35-45.
1979
-
Second cessation of therapy in childhood lymphocytic leukemia..
53:1114-1120.
1979
-
Arsenic-induced bone marrow toxicity: ultrastructural and electron-probe analysis..
53:820-827.
1979
-
Purification and characterization of papain-solubilized HLA antigens from human platelets..
53:838-850.
1979
-
Analysis of late infections in 89 long-term survivors of bone marrow transplantation..
53:720-731.
1979
-
Hairy cell leukemia: cellular characteristics including surface immunoglobulin dynamics and biosynthesis..
53:764-765.
1979
-
In vitro kinetics of immunoglobulin synthesis and secretion by nonsecretory human myeloma cells..
50:1031-1038.
1977
-
Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia..
50:671-682.
1977
-
Pretreatment cytokinetic studies in 94 children with acute leukemia. Relationship to other variables at diagnosis and to outcome of standard treatment..
49:683-691.
1977
-
NEUTROPHIL PARALYSIS ASSOCIATED WITH CONGENITAL ABSENCE OF A SPECIFIC GLYCOPROTEIN.
50:293-293.
1977
-
Human lymphocyte motility: normal characteristics and anomalous behavior of chronic lymphocytic leukemia cells..
48:717-729.
1976
-
Intranuclear inclusions in Bence Jones lambda plasma cell myeloma..
45:131-139.
1975
-
A monoclonal IgM with antibodylike specificity for phospholipids in a patient with lymphoma..
43:493-504.
1974
-
Isoantibody specificity in post-transfusion purpura..
41:817-822.
1973
-
Enzymatic studies in the different types of normal and leukemic human white cells..
18:317-327.
1961
-
Tackling T-cell tumors.
102:2313-2313.
2003
-
Annual Healthcare Resource Utilization and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia
2020
-
Barriers and Facilitators of Advance Care Planning for Older Adults with Sickle Cell Disease
2020
-
COVID-19 Associated Coagulopathy: Thrombosis, Hemorrhage and Mortality Rates with an Escalated-Thromboprophylaxis Strategy
2020
-
Comparison of End-of-Life Care Quality Outcomes and Indicators of Palliative Needs between Medicare Beneficiaries with Solid and Hematologic Malignancies
2020
-
Decisional Involvement, Information Preferences, and Prognostic Optimism Among Patients with Hematologic Malignancies
2020
-
Factors Associated with High Healthcare Utilization at the End-of-Life (EOL) for Patients with Acute Myeloid Leukemia
2020
-
Financial Burden Is Associated with Postponing Care and Decreasing Physical and Emotional Quality of Life Among Patients with Multiple Myeloma and Chronic Lymphocytic Leukemia
2020
-
Frontline Bendamustine and Rituximab in Extranodal Marginal Zone Lymphoma: An International Analysis
2020
-
Genome Wide Association Analysis of Iron Overload in the Trans-Omics for Precision Medicine (TOPMed) Sickle Cell Disease Cohorts
2020
-
How Do Progression-Free Survival and Toxicity Risks Influence Oncologist and Patient Preferences for Novel Agents in Chronic Lymphocytic Leukemia?
2020
-
Indirect Treatment Comparison of CC-486 Versus Azacitidine (AZA) As Maintenance Therapy for Acute Myeloid Leukemia (AML)
2020
-
Morphologic Leukemia-Free State in Acute Myeloid Leukemia Is Sufficient for Successful Allogeneic Hematopoietic Stem Cell Transplant
2020
-
Multi-Site Randomized Trial of Integrated Palliative and Oncology Care for Patients with Acute Myeloid Leukemia (AML)
2020
-
Patient Experiences with Liposomal Daunorubicin and Cytarabine (CPX-351) Versus Conventional Induction Regimens: An Analysis of Patient-Reported Outcomes Data from a Prospective Trial
2020
-
Post-Traumatic Stress Disorder (PTSD) Symptoms in Patients with Acute Myeloid Leukemia (AML)
2020
-
Restoration of Normal Blood Flow in Mouse Models of Sickle Cell Vaso-Occlusion Following Intravenous or Subcutaneous Administration of a Highly Potent E-Selectin Specific Inhibitor
2020
-
Targeting the Glucagon Receptor Signaling Pathway As a Novel Strategy to Counteract PI3K Inhibitor Induced Hyperglycemia While Sustaining Tumor PI3K Inhibition
2020
-
Treatment Decision-Making and Decisional Support Experiences Among Acute Myeloid Leukemia Survivors
2020
-
A Phase 1b/2 Study of Selinexor, Carfilzomib, and Dexamethasone (SKd) in Relapsed/ Refractory Multiple Myeloma (RRMM)
2019
-
A Retrospective Review of Hospital-Acquired Venous Thromboembolism at a Large Pediatric Tertiary Care Center
2019
-
Addition of Drug-Response Specific Micro-RNAs to the International Prognostic Index Improves Prognostic Stratification of GCB-DLBCL Patients Treated with R-CHOP
2019
-
Anaerobic Antibiotics and the Risk of Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
2019
-
Aptamers as Rapid Onset and Rapidly Reversible Antithrombotic Agents
2019
-
Biomarker Modulation By Mivebresib (ABBV-075) +/- Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia
2019
-
Cancer-Related Distress and Unmet Needs Among Acute Myeloid Leukemia Survivors
2019
-
Cell of Origin Classification of DLBCL Using Targeted NGS Expression Profiling and Deep Learning
2019
-
Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency
2019
-
Clinical Outcomes and Health-Related Quality of Life (HRQoL) Among Randomized Clinical Trial (RCT)-Eligible and RCT-Ineligible Patients: Results from the Connect® MM Registry
2019
-
Clinical Profile of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
2019
-
Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell Transplantation
2019
-
Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency
2019
-
Daily Chlorhexidine Gluconate Bathing Reduces the Rate of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Stem Cell Transplantation
2019
-
Decreased Mortality after the First Year of Allogeneic Hematopoietic Stem Cell Transplant in Recipients of Umbilical Cord Blood Vs. Matched Related or Matched Unrelated Donors
2019
-
Durable Remission and Long-Term Survival in Relapsed/Refractory (r/r) AML Patients Treated with Guadecitabine, Median Survival Not Reached for Responders after Long Term Follow up from Phase 2 Study of 103 Patients
2019
-
Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies
2019
-
Evaluation of the Oral SYK Inhibitor Fostamatinib in Patients after Allogeneic Transplantation for Chronic Graft-Versus-Host Disease
2019
-
Financial Incentives to Increase Stool Collection Rates for Microbiome Studies in Adult Bone Marrow Transplant Patients
2019
-
Flotetuzumab, an Investigational CD123 x CD3 Bispecific Dart® Protein, in Salvage Therapy for Primary Refractory and Early Relapsed Acute Myeloid Leukemia (AML) Patients
2019
-
Geriatric Assessment Identifies Impairments in Younger Candidates for Allogeneic Hematopoietic Stem Cell Transplantation
2019
-
Higher Stability of Mutant mRNA As Compared to Wild-Type mRNA in Diffuse Large B-Cell Lymphoma
2019
-
Identification of Optimal Thalassemia Screening Strategies for Migrant Populations in Thailand: A Mixed-Methods Approach
2019
-
Impact of Capacity Development Program on Outcomes for Pediatric Hematologic Malignancies in Tanzania
2019
-
Improvement in Cytokine Release Syndrome Management for the Treatment of AML Patients with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Molecule for T-Cell Redirected Therapy
2019
-
Incidence of Invasive Fungal Infections in Acute Leukemia Patients Utilizing Micafungin Prophylaxis Compared to Second-Generation Azole Prophylaxis
2019
-
Microrna-191 Regulates T-Cell Clonal Expansion during Graft-Versus-Host Disease
2019
-
Mn Porphyrin-Based Redox Active Drugs Improve Anemia and Reduce Organ Damage in a Murine Model of Sickle Cell Disease
2019
-
No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Compared to Conventional CBT: Results of a Randomized Trial
2019
-
Oral Adherence in Adults with Acute Myeloid Leukemia: Results of a Mixed Methods Study
2019
-
Outcomes in Patients with Therapy-Related Acute Myeloid Leukemia (t-AML) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis
2019
-
Phase 1 Single (SAD) and Multiple Ascending Dose (MAD) Studies of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of FT-4202, an Allosteric Activator of Pyruvate Kinase-R, in Healthy and Sickle Cell Disease Subjects
2019
-
Phase I/II Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Dexamethasone As Targeted Therapy for Patients with t(11;14) Relapsed/Refractory Multiple Myeloma
2019
-
Physical Function, Pain Severity, and Fatigue in Patients with Relapsed/Refractory Multiple Myeloma: Health-Related Quality of Life Results in Patients Receiving Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone
2019
-
Pre-Transplant Hepatic Steatosis (fatty liver) Predicts Chronic Graft-Vs-Host Disease but Does Not Affect Mortality
2019
-
Proteomic Discovery: Elevated Neurogranin Levels in Children with Sickle Cell Disease
2019
-
Pyruvate Kinase (PK) Protein and Enzyme Levels in the Diagnosis and Clinical Phenotype of PK Deficiency
2019
-
Real-World Treatment Patterns and Overall Survival Among Medicare Fee-for-Service Beneficiaries Newly Diagnosed with Peripheral T-Cell Lymphoma
2019
-
Results from Phase 1/2 Trial of Tagraxofusp in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
2019
-
Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Newly Diagnosed Multiple Myeloma
2019
-
Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics from a Phase I Study of PF-06863135, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
2019
-
Selinexor in Combination with Induction and Consolidation Therapy in Older Adults with AML Is Highly Active
2019
-
Selinexor, Pomalidomide, and Dexamethasone (SPd) in Patients with Relapsed or Refractory Multiple Myeloma
2019
-
Single-Cell RNA-Seq Identifies Potentially Pathogenic B Cell Populations That Uniquely Circulate in Patients with Chronic Gvhd
2019
-
T(11;14) and High BCL2 Expression Are Predictive Biomarkers of Response to Venetoclax in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Biomarker Analyses from the Phase 3 Bellini Study
2019
-
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies
2019
-
Treatment Decision Making in AML: Factors of Importance to Clinicians, AML Patients and Their Family
2019
-
Treatment Patterns and Outcomes in Elderly Patients with Newly Diagnosed Multiple Myeloma: Results from the Connect® MM Registry
2019
-
Understanding Clinician and Patient Preferences about Novel Agents in Chronic Lymphocytic Leukemia
2019
-
Updated Analysis of Bellini, a Phase 3 Study of Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
2019
-
2nd cycle Remission Achievement with 7+3 Is Associated with Shorter Survival in Adults with Newly Diagnosed Acute Myeloid Leukemia: Analysis of Recent SWOG Trials
2018
-
A Phase 2 Study of Actinium-225 (225Ac)-Lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML) - Interim Analysis of 1.5 µci/Kg/Dose
2018
-
A Phase I, First-in-Human Study Evaluating the Safety and Preliminary Antileukemia Activity of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Other CD123-Positive Hematologic Malignancies
2018
-
A Phase I, Open-Label Study to Evaluate the Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity of PF-06863135, a B-Cell Maturation Antigen/CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Advanced Multiple Myeloma
2018
-
A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy Vs. Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL): A Trial of the ECOG-ACRIN Cancer Research Group (E1912)
2018
-
Allergic Sensitization Is Associated with Decreased Risk of ED Visits and Hospitalizations for Pain in Sickle Cell Disease
2018
-
Allogeneic Hematopoietic Cell Transplantation (HCT) Vs. Non-HCT Consolidation Therapies in Acute Myeloid Leukemia (AML) Patients 60-75 Years of Age in First Complete Remission (CR1): An Alliance (A151509), SWOG, ECOG-ACRIN and CIBMTR Study
2018
-
Calcium/Calmodulin Dependent Protein Kinase Kinase 2 (CaMKK2) Expressed in the Host Promotes Lymphoma Cells Growth By Controlling Myeloid Derived Suppressor Cells Expansion
2018
-
Deep and Durable Responses with Selinexor, Daratumumab, and Dexamethasome (SDd) in Patients with Multiple Myeloma (MM) Previously Exposed to Proteasome Inhibitors and Immunomodulatory Drugs: Results of Phase 1b Study of SDd
2018
-
Disparities in Foundation and Federal Support and Development of New Therapeutics for Sickle Cell Disease and Cystic Fibrosis
2018
-
ET190L1-ArtemisTM T Cell Therapy Results in Durable Disease Remissions with No Cytokine Release Syndrome or Neurotoxicity in Patients with Relapsed and Refractory B-Cell Lymphoma
2018
-
Early Results from a Biomarker-Directed Phase 2 Trial of Sy-1425 in Combination with Azacitidine or Daratumumab in Non-APL Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
2018
-
End-of-Life Care Quality Outcomes Among Medicare Beneficiaries with Hematologic Malignancies
2018
-
Endothelial Cell-Derived Extracellular Vesicles Mitigate Radiation-Induced Hematopoietic Injury
2018
-
Exercise and Chronic Lymphocytic Leukemia (CLL) - Relationships Among Physical Activity, Fitness, & Inflammation, and Their Impacts on CLL Patients
2018
-
Health Related Quality of Life and Fatigue in Patients with Pyruvate Kinase Deficiency
2018
-
Healthcare Resource Utilization (HCRU) in Patients (pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Treated in the Connect® MDS/AML Disease Registry
2018
-
Ibrutinib Alone or in Combination with Rituximab Produces Superior Progression Free Survival (PFS) Compared with Bendamustine Plus Rituximab in Untreated Older Patients with Chronic Lymphocytic Leukemia (CLL): Results of Alliance North American Intergroup Study A041202
2018
-
Intestinal Enterococcus Is a Major Risk Factor for the Development of Acute Gvhd
2018
-
Ivosidenib (AG-120) Induced Durable Remissions and Transfusion Independence in Patients with IDH1-Mutant Untreated AML: Results from a Phase 1 Dose Escalation and Expansion Study
2018
-
Knowledge, Cultural, and Structural Barriers to Thalassemia Screening in Migrant Populations in Thailand
2018
-
Lenalidomide Plus Hypomethylating Agent for Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities -AML with Inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, Mecom
2018
-
Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observational Study
2018
-
Loss of Microbiota Diversity after Autologous Stem Cell Transplant Is Comparable to Injury in Allogeneic Stem Cell Transplant
2018
-
Management of Cytokine Release Syndrome in AML Patients Treated with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Molecule for T-Cell Redirected Therapy
2018
-
Maturing Clinical Profile of IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Acute Myeloid Leukemia
2018
-
Mn Porphyrin-Based Redox Active Drugs As Novel Anti-Adhesive and Anti-Inflammatory Agents Targeting Sickle Red Blood Cell Oxidative Damage In Vivo
2018
-
Multicenter Microbiota Analysis Indicates That Pre-HCT Microbiota Injury Is Prevalent across Geography and Predicts Poor Overall Survival
2018
-
Omission of Maintenance in Patients with High-Risk Acute Promyelocytic Leukemia (APL) in the Era of ATRA/Arsenic Consolidation
2018
-
Outcomes of Acute Myeloid Leukemia Patients with Indeterminate Day 14 Bone Marrow Results Treated with and without Re-Induction Chemotherapy
2018
-
Palliative Care Physicians' Views Toward Hematology and the Care of Patients with Hematologic Diseases: Results of a Nationwide Survey
2018
-
Patients' Perspectives on the Definition of Cure in Chronic Myeloid Leukemia: A US Based Survey
2018
-
Pediatric Patient-Reported Symptom Tracking in Oncology (Pedi-PReSTO): A Feasibility Study
2018
-
Phase 1 Cohort Expansion of Flotetuzumab, a CD123×CD3 Bispecific Dart® Protein in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
2018
-
Predicting Induction Toxicity with 7+3: Analysis of SWOG Trial S1203
2018
-
Predictors of Patient-Reported Communication with Their Health Care Team about New Treatment Options for Chronic Lymphocytic Leukemia
2018
-
Rapid and Robust CD4+ and CD8+ T-, NK-, B- and Monocyte Cell Reconstitution after Nicotinamide-Expanded Cord Blood Transplantation
2018
-
Results from a Phase II Study of Isatuximab As a Single Agent and in Combination with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
2018
-
Results of Pivotal Phase 2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
2018
-
Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with Newly Diagnosed Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia
2018
-
Selinexor Plus Pomalidomide and Low Dose Dexamethasone (SPd) in Patients with Relapsed or Refractory Multiple Myeloma
2018
-
Sleep Disturbance Among Individuals with Multiple Myeloma: The Interplay between Physical and Psychosocial Symptoms
2018
-
Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: A Large Real-Time Multi-Center Prospective Longitudinal Observational Study
2018
-
The Impact of Cumulative Dose of Cytarabine Consolidation on Outcomes in Older Patients with Acute Myeloid Leukemia
2018
-
Treatment Choices and Outcomes for Patients with Multiple Myeloma after Relapse on Lenalidomide Maintenance Therapy: Results from the Connect® MM Registry
2018
-
Treatment Decision Making and Treatment Satisfaction Among Individuals Living with Chronic Myeloid Leukemia
2018
-
Treatment with Foscarnet after Allogeneic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function
2018
-
Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia
2018
-
Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor — Recipient Pairs Is Associated with High Levels of Donor Chimerism and Donor-Specific Tolerance to Kidney Allografts
2018
-
hnRNP K: A Regulator of Global Transcription and Translation That Drives Lymphomagenesis
2018
-
Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival ("Potential Cure") over the Past Four Decades: Analysis of SWOG Trial Data
2017
-
Beliefs and Patterns of Practice in the Management of Hyperleukocytosis and Leukostasis Among Health Care Providers for Patients with Acute Leukemia: A Large North American Web-Based Survey
2017
-
Clinical Outcomes of Microtransplantation for Older Adults with Acute Myeloid Leukemia
2017
-
Clinical Significance of PD-1 and PD-L1 Expression and Ongoing Interaction in the Tumor Microenvironment in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP
2017
-
Early Results from a Biomarker-Directed Phase 2 Trial of Sy-1425 in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Demonstrate DHRS3 Induction and Myeloid Differentiation Following Sy-1425 Treatment
2017
-
Evaluation of Residual Disease Positivity Rates in Adult Acute Lymphoblastic Leukemia Patients Treated with Asparaginase Versus Non-Asparaginase Containing Regimens
2017
-
Favorable Outcomes with Fludarabine, High Dose Cytarabine and Granulocyte Colony Stimulating Factor (FLAG) As Re-Induction for Residual Acute Myeloid Leukemia on Day 14 Bone Marrow
2017
-
Financial Burden and Patient-Reported Outcomes after Hematopoietic Cell Transplantation: Impact of Pre-Treatment Awareness of Transplant-Associated Costs
2017
-
IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate (ADC) Demonstrates Initial Antileukemia Activity in Patients with Relapsed or Refractory Acute Myeloid Leukemia
2017
-
Insurance Design and Out-of-Pocket (OOP) Costs: a Comparison of Oral and Intravenous (IV) Treatment Plans for Chronic Lymphocytic Leukemia (CLL) in the Era of the Affordable Care Act (ACA)
2017
-
Ivosidenib (AG-120) in Mutant IDH1 AML and Advanced Hematologic Malignancies: Results of a Phase 1 Dose Escalation and Expansion Study
2017
-
Multiple Myeloma Symptom Burden, Perceived Control, and Quality of Life: Findings from the Cancer Experience Registry
2017
-
PD-L1 Expression and Gene Amplification in CD30+Diffuse Large B-Cell Lymphoma (DLBCL): Significance of TP53 Genetic Impact and Clinicopathologic Characteristics
2017
-
Patient-Reported Distress in Hodgkin Lymphoma Patients on Active Therapy Vs. Long-Term Survivors
2017
-
Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults
2017
-
Perceptions of Prognosis and Treatment Risk in Older Patients with Acute Myeloid Leukemia
2017
-
Pre-Transfusion Rejuvenation of RBCs for Red Blood Cell Exchange: Report of Feasibility
2017
-
Prospective Study of Acute Myeloid Leukemia (AML) Clinical Epidemiology and Cytogenetic Risk Group in Older Adults in the ECOG-ACRIN E2906 Clinical Trial: The Acute Leukemia Epidemiology, Survival and Endpoints (ALESE) Study
2017
-
Quantification of Whole-Brain Oxygenation Extraction Fraction Among People with Sickle Cell Anemia without Stroke History
2017
-
Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib
2017
-
Results from the US Life after Stopping TKIs (LAST) Study
2017
-
Role of Glucose Transporter 1 in Graft-Versus-Host Disease and Graft-Versus-Tumor Effect
2017
-
The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation
2017
-
The Timing and Epidemiology of Enterococcus Faecium and E. Faecalis Bloodstream Infections (BSI) in Patients with Acute Leukemia Receiving Chemotherapy
2017
-
Transcript Expression, Intron Retention, and RNA Editing Are Conserved in Human Platelets over a 4 Year Period
2017
-
Transfusion Dependence and Use of Hospice Among Medicare Beneficiaries with Leukemia
2017
-
Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia in Real-World US Practices
2017
-
A Comparison of an Individualized and Weight-Based Opioid Protocols for the Treatment of Vaso-Occlusive Episodes in the Emergency Department
2016
-
A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia (SWOG 1312)
2016
-
A Phase 1/2 Study of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
2016
-
A Phase 1b Study of Vadastuximab Talirine As Maintenance and in Combination with Standard Consolidation for Patients with Acute Myeloid Leukemia (AML)
2016
-
A Phase 1b Study of Vadastuximab Talirine in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
2016
-
A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)
2016
-
Adult Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation, Fludarabine, and Thiotepa Conditioning
2016
-
All-Trans Retinoic Acid (ATRA) Targets IRF4 Deficient, NOTCH2-Activated B Cells from Chronic Gvhd Patients
2016
-
Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke (CoBIS): Clinical Outcomes from a Phase 1 Safety Study
2016
-
Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
2016
-
Aptamer Mediated Inhibition of Protein S
2016
-
Association of BW with Thromboembolic and Bleeding Outcomes in Phase III Randomized Controlled Trials of Direct Oral Anticoagulants: Systematic Review and Meta-Analysis
2016
-
Cell-Free DNA Is Elevated after Acute Arterial Injury in Infants
2016
-
Clinical Characteristics and Quality of Life of Children with ITP Starting Second Line Treatments: Data from the ITP Consortium of North America ICON1 Study
2016
-
Comparable Outcomes of Patients Eligible Versus Ineligible for Southwest Oncology Group (SWOG) Leukemia Studies
2016
-
Complete Remissions (CRs) with Azacitidine Regimens Compared to Crs with 7+3 Induction Chemotherapy and the Effect on Overall Survival
2016
-
Cost-Effectiveness of Blood Transfusions Versus Observation for Silent Cerebral Infarcts from the Silent Cerebral Infarct Trial
2016
-
Current Diagnosis Patterns for Acute Myeloid Leukemia (AML) in Clinical Practice Compared with World Health Organization (WHO) 2008 Recommendations: Outcomes from the CONNECT® Myelodysplastic Syndromes (MDS) and AML Disease Registry
2016
-
Durable Overall Survival Benefit in Patients ≥ 60 Years with Relapsed or Refractory AML Treated with Vosaroxin/Cytarabine Vs Placebo/Cytarabine: Updated Results from the Valor Trial
2016
-
EGF Accelerates Hematopoietic Stem Cell Regeneration Following 5-FU Chemotherapy Via G-CSF Receptor Signaling
2016
-
ENESTgoal Treatment-Free Remission Study: Updated Preliminary Results and Digital Polymerase Chain Reaction Analysis in Patients with Chronic Myeloid Leukemia in Chronic Phase Who Switched from Imatinib to Nilotinib
2016
-
ETS1 Phosphorylation at Threonine-38 Is a Marker of B Cell Receptor Activation, Associating with Cell of Origin and Outcome in Diffuse Large B Cell Lymphoma
2016
-
Effect of FXIII Polymorphism on Formation of Heterocellular Aggregates in SCD
2016
-
Factors Related to the Progression of Sickle Cell Disease Nephropathy
2016
-
Feasibility of Allogeneic Hematopoietic Cell Transplantation Among High-Risk AML Patients in First Complete Remission: Results of the Transplant Objective from the SWOG (S1203) Randomized Phase III Study of Induction Therapy Using Standard 7+3 Therapy or Idarubicin with High-Dose Cytarabine (IA) Versus IA Plus Vorinostat
2016
-
Final Results of the Chrysalis Trial: A First-in-Human Phase 1/2 Dose-Escalation, Dose-Expansion Study of Gilteritinib (ASP2215) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
2016
-
Fingolimod Is Cytotoxic in Acute Myeloid Leukemia Independent of Additional Chemotherapeutic Agents
2016
-
GWAS Meta-Analysis of Glomerular Filtration Rate in Three Cohorts of Sickle Cell Disease Patients and In Vivo Functional Analysis Reveals Potential Nephropathy Candidate Genes
2016
-
Health-Related Quality of Life of Patients with Newly Diagnosed Multiple Myeloma Receiving Any or Lenalidomide Maintenance after Autologous Stem Cell Transplant in the Connect® MM Disease Registry
2016
-
Impact of Wait Times for Autologous Stem Cell Transplantation in Patients with Aggressive Non-Hodgkin Lymphoma, a Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial
2016
-
Improved Prognostic Significance of Genomic and Transcriptional Biomarkers By Examining Enriched Populations of AML Blasts: A SWOG Report
2016
-
Long Term Survival and Clinical Complete Responses of Various Prognostic Subgroups in 103 Relapsed/Refractory Acute Myeloid Leukemia (r/r AML) Patients Treated with Guadecitabine (SGI-110) in Phase 2 Studies
2016
-
Mechanism of Complement Activation By PF4/ Heparin Complexes
2016
-
Novel ELISA-Based Assay for Detection of Complement Activation By PF4/Heparin Complexes
2016
-
PCTP (Phosphatidylcholine Transfer Protein) is Regulated By RUNX1 in Platelets/Megakaryocytes and is Associated with Adverse Cardiovascular Events
2016
-
Physician Factors Determining Treatment Decisions in Selecting Second Line Agents for Pediatric ITP
2016
-
Postoperative Venous Thromboembolism in Children Is Increased in Setting of Cancer or Infection
2016
-
Prospective Implementation of Multi-Disciplinary Obstetric Team Decreases the Mortality Rate of Pregnant Women with Sickle Cell Disease in Ghana
2016
-
RNA Aptamer Against FXa Synergizes with FXa Catalytic Site Inhibitors to Effectively and Reversibly Anticoagulate Blood in an Ex Vivo Oxygenator Circuit
2016
-
Recipient-Derived BAFF and Alloantigen Synergistically Activate B Cells in Murine Chronic Gvhd
2016
-
Results from Ongoing Phase 1/2 Trial of SL-401 in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
2016
-
Results from Ongoing Phase 2 Trial of SL-401 As Consolidation Therapy in Patients with Acute Myeloid Leukemia (AML) in Remission with High Relapse Risk Including Minimal Residual Disease (MRD)
2016
-
Results from Phase 2 Trial Ongoing Expansion Stage of SL-401 in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
2016
-
Results of a Clinical Study of Pevonedistat (Pev), a First-in-Class NEDD8-Activating Enzyme (NAE) Inhibitor, Combined with Azacitidine (Aza) in Older Patients (Pts) with Acute Myeloid Leukemia (AML)
2016
-
Ruxolitinib Used to Treat Hypereosinophilic Syndrome
2016
-
SWOG S1203: A Randomized Phase III Study of Standard Cytarabine Plus Daunorubicin (7+3) Therapy Versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)
2016
-
Safety and Efficacy of Carfilzomib (CFZ) in Previously-Treated Systemic Light-Chain (AL) Amyloidosis
2016
-
Short Course of Bendamustine and Rituximab Followed By 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naive Follicular Lymphoma (FOL-BRITe): Final Report of Response Rates and Progression Free Survival
2016
-
Simultaneous Measurement of Cerebral Blood Flow and Arterial Transit Time for Sickle Cell Disease
2016
-
Successful Engraftment of Donor Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord® (Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and a Second Unmanipulated Cord Blood Unit after Myeloablative Chemotherapy in Pediatric Patients with Severe Sickle Cell Disease
2016
-
Surface CD5 Protein Risk Stratifies Chronic Lymphocytic Leukemia
2016
-
Survival after Relapse Following Tandem Allogeneic Vs. Tandem Autologous Hematopoietic Cell Transplantation (HCT) for Myeloma (MM)
2016
-
The Safety and Efficacy of Full Versus Reduced Dose Betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention with Extended Duration Betrixaban (APEX) Trial
2016
-
Three Factor Prothrombin Complex Concentrates in Cardiac Surgery: A Novel Algorithmic Approach to Perioperative Bleeding
2016
-
Thrombospondin-1 Polymorphisms Are Associated with Chronic Kidney Disease in Sickle Cell Anemia
2016
-
Toxicities and Related Outcomes of Elderly Patients (pts) (≥65 Years) with Hematologic Malignancies in the Contemporary Era (Alliance A151611)
2016
-
Transformation in Pre-Treatment Presentations of Gaucher Disease during the First Two Decades of Imiglucerase Enzyme Replacement Therapy: A Report from the International Collaborative Gaucher Group Gaucher Registry
2016
-
Treatment Patterns from 2009 to 2015 in Patients with Newly Diagnosed Multiple Myeloma in the United States: A Report from the Connect® MM Registry
2016
-
Umbilical Cord Blood (UCB) Transplantation in Children with Acute Leukemia: Impact of Conditioning Regimen on Transplant Outcomes
2016
-
Use of Mobile Technology to Monitor Pain and Reduce Outpatient, Emergency Department (ED), and Hospital Visits for Sickle Cell Pain Crisis
2016
-
Vadastuximab Talirine Monotherapy in Older Patients with Treatment Naive CD33-Positive Acute Myeloid Leukemia (AML)
2016
-
Vadastuximab Talirine Plus Hypomethylating Agents: A Well-Tolerated Regimen with High Remission Rate in Frontline Older Patients with Acute Myeloid Leukemia (AML)
2016
-
Variation in Serial TCD Velocity Measurements in the TCD with Transfusions Changing to Hydroxyurea (TWiTCH) Trial
2016
-
Venetoclax Monotherapy for Relapsed/Refractory Multiple Myeloma: Safety and Efficacy Results from a Phase I Study
2016
-
Von Willebrand Factor to Prevent Postpartum Hemorrhage
2016
-
A Dose Finding Phase II Trial of Isatuximab (SAR650984, Anti-CD38 mAb) As a Single Agent in Relapsed/Refractory Multiple Myeloma
2015
-
A Phase 1 Study of the DOT1L Inhibitor, Pinometostat (EPZ-5676), in Adults with Relapsed or Refractory Leukemia: Safety, Clinical Activity, Exposure and Target Inhibition
2015
-
A Phase 1 Trial of SGN-CD33A As Monotherapy in Patients with CD33-Positive Acute Myeloid Leukemia (AML)
2015
-
A Phase I-II Study of the Combination of Bendamustine and Pomalidomide with Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma.
2015
-
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies
2015
-
AAV Gene Therapy for MPS1 Corneal Clouding and Joint Stiffness
2015
-
Additional Analyses of a Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117
2015
-
Antileukemic Activity and Tolerability of ASP2215 80mg and Greater in FLT3 Mutation-Positive Subjects with Relapsed or Refractory Acute Myeloid Leukemia: Results from a Phase 1/2, Open-Label, Dose-Escalation/Dose-Response Study
2015
-
Autologous Cord Blood Infusion for the Treatment of Brain Injury in Children with Cerebral Palsy
2015
-
Autologous Hematopoietic Cell Transplantation in Patients with High Risk Multiple Myeloma: Post- Transplant Responses Do Not Translate to Longer Survival
2015
-
Baseline Predictors of Mortality in Patients with Relapsed or Refractory Acute Myeloid Leukemia Treated with Vosaroxin Plus Cytarabine or Placebo Plus Cytarabine in the Phase 3 VALOR Study
2015
-
Characterization of Human and Murine Anti-Protamine/Heparin Antibodies
2015
-
Clinical Outcomes of Patients with Newly Diagnosed Multiple Myeloma Receiving Triplet Therapy in the Connect MM (R) Disease Registry
2015
-
Combination Treatment of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib and Carfilzomib in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Initial Results from a Multicenter Phase 1/2b Study
2015
-
Cord Blood Unit Cryopreservation: Positioning Segments for Potency Assessment
2015
-
Cost of Hospitalization in Patients with Cancer and Febrile Neutropenia and Impact of Comorbid Conditions
2015
-
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial
2015
-
Defining the Genomic Make up of Acute Myeloid Leukemia in Adolescents and Young Adults (AYA): Report from COG AAML03P1, AAML531 and SWOG S0106
2015
-
Development of an Online Patient Decision Aid for Previously Treated Mantle Cell Lymphoma
2015
-
Dickkopf 1 (Dkk1) Regulates Hematopoietic Stem Cell Regeneration
2015
-
Diffuse Large B-Cell Lymphoma Cell of Origin Determination from Formalin-Fixed Paraffin-Embedded Tissues
2015
-
ENESTnext Final Results: Deep Molecular Response (MR) with Nilotinib (NIL) in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
2015
-
Early Allogeneic Stem Cell Transplantation and Use of Asparaginase during Induction Chemotherapy Appear to Improve Otherwise Poor Outcomes in Adult T Cell Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/T-LBL) Patients: A Multi Institutional Review
2015
-
Effect of Minimal Residual Disease (MRD) Information on Prediction of Relapse and Survival in Adult Acute Myeloid Leukemia
2015
-
Functional Analysis of the CML Blast Crisis Transcriptome and Epigenome Using Crispr-CAS9 and Pharmacologic Approaches
2015
-
Genome-Wide Evaluation of Epistasis with APOL1 Risk Variants in Sickle Cell Disease Nephropathy
2015
-
Growth Factor Receptor-Bound Protein 10 (Grb10) Regulates Hematopoietic Stem Cell (HSC) Self-Renewal Via Control of mTOR Signaling
2015
-
Health Care Utilization and End of Life Care for Older Patients with Acute Myeloid Leukemia Receiving Supportive Care Alone
2015
-
Impact of Available Therapies on Survival of Very Elderly Myelodysplastic Syndrome (MDS) Patients (Age above 75 yrs)
2015
-
Impact of GvHD and Other Patient-, Disease-, Donor and Transplantation-Related Factors on 5 Year Relapse after Unrelated Cord Blood Transplantation for Children with Acute Lymphoblastic Leukemia in Remission
2015
-
Lead-in Stage Results of a Pivotal Trial of SL-401, an Interleukin-3 Receptor (IL-3R) Targeting Biologic, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) or Acute Myeloid Leukemia (AML)
2015
-
Long-Term Follow-up Results: A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed c-Kit Positive Acute Myeloid Leukemia (AML)
2015
-
Molecular Characterization of 140 Patients in the Pyruvate Kinase Deficiency (PKD) Natural History Study (NHS): Report of 20 New Variants
2015
-
Multi-Center US Intergroup Study of Intensive Chemotherapy Plus Dasatinib Followed By Allogeneic Stem Cell Transplant in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Younger Than 60
2015
-
Multiple Myeloma Patient Experience with Financial Toxicity: Findings from the Cancer Experience Registry
2015
-
North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute Leukemia
2015
-
Outcomes for Older Patients with Acute Myeloid Leukemia Admitted to the Intensive Care Unit
2015
-
Post-Transplant Therapy Is More Important Than Induction Regimen Choice in Autologous Hematopoietic Cell Transplantation (AHCT) Recipients for Multiple Myeloma (MM)
2015
-
Potentially Avoidable Hospitalizations in Older Patients with Acute Myeloid Leukemia (AML)
2015
-
Prognostic Methylation Markers for Survival in Cytogenetically Normal AML Patients Treated on SWOG Trials
2015
-
Prothrombin Complex Concentrates and Cardiac Surgery
2015
-
Rapid Achievement of MR4.5 after Switching from Imatinib (IM) to Nilotinib (NIL) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Preliminary Results from ENESTgoal
2015
-
Reduced Intensity Continuous Infusion Busulfan for Allogeneic Hematopoietic Cell Transplant Patients with Hematologic Disorders Who Are Ineligible or Inappropriate for Treatment with a More Intensive Therapeutic Regimen: LCCC 0306
2015
-
Report of the Relapsed/Refractory Cohort of SWOG S0919: A Phase 2 Study of Idarubicin and Cytarabine in Combination with Pravastatin for Acute Myelogenous Leukemia
2015
-
Results of a Multicenter Pilot Investigation of Bone Marrow Transplantation in Adults with Sickle Cell Disease (STRIDE)
2015
-
Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901
2015
-
SGN-CD33A Plus Hypomethylating Agents: A Novel, Well-Tolerated Regimen with High Remission Rate in Frontline Unfit AML
2015
-
Symptom Burden, Quality of Life, and Distress in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy: Results of a Prospective Electronic Patient-Reported Outcomes Study
2015
-
TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia
2015
-
Targeting the Human Notch 2-BCR Axis: A Driver of B-Cell Hyper-Responsiveness in Active Chronic Graft-Versus Host Disease (cGVHD)
2015
-
The Genomic and Epigenomic Landscapes of Blast Crisis Transformation in Chronic Myeloid Leukemia
2015
-
The Phenotypic Spectrum of Pyruvate Kinase Deficiency (PKD) from the PKD Natural History Study (NHS): Description of Four Severity Groups By Anemia Status
2015
-
The Thrombotic Microangiopathy Registry of North America
2015
-
Thrombocytopenia in Hospitalized Non-ICU Patients
2015
-
beta-arrestin2 Is Necessary for Development of MPLW515L Mutant Primary Myelofibrosis
2015
-
A Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes with Prognosis
2014
-
A Multi-Center Phase 1b, Open-Label, Dose-Finding Pilot Study to Evaluate the Combination of Carfilzomib and Cyclophosphamide with Dexamethasone (CCyD) Prior to Autologous Stem Cell Transplant (ASCT) in Patients with Transplant Eligible Newly Diagnosed Multiple Myeloma
2014
-
A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis
2014
-
A Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117
2014
-
Acute and Chronic Lymphocytic Leukemia Induces Exhaustion and Suppresses Metabolic Reprogramming in T Cell Activation
2014
-
Akt Activation Confers an Inferior Survival in Patients with Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program
2014
-
An Open-Label, Dose Escalation, Multi-Center Phase 1 Study of PRLX 93936, an Agent Synthetically Active Against the Activated Ras Pathway, in the Treatment of Relapsed or Relapsed and Refractory Multiple Myeloma
2014
-
Atomic Level Description of the Immune Complex That Causes Heparin-Induced Thrombocytopenia (HIT)
2014
-
Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization By Patients with Sickle Cell Disease
2014
-
Biologic Activities of Protamine/Heparin Antibodies
2014
-
Broncho-Alveolar Lavage and Lung Biopsy in Patients with Hematological Malignancy and Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review and Meta-Analysis
2014
-
Calcium Calmodulin Dependent Kinase Kinase 2 Regulates Hematopoietic Stem Cell Regeneration and Quiescence
2014
-
Clinical and Biological Features of Primary Testicular B-Cell Lymphoma - a Single-Institution Study of 89 Cases
2014
-
Clinician Approaches to Myeloma in Academia and the Community : An in-Practice Qualitative Study
2014
-
Connect MM (R) the Multiple Myeloma (MM) Disease Registry: Incidence of Second Primary Malignancies (SPM)
2014
-
Connect MM (R) the Multiple Myeloma (MM) Disease Registry: Interim Analysis of Overall Survival and Outcomes in Patients with High-Risk Disease
2014
-
Deep Molecular Response in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib: ENESTnext Update
2014
-
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival
2014
-
Defining Immunoglobulin Somatic Hypermutation in De Novo Diffuse Large B-Cell Lymphoma Patients: Potential Application for Prognosis and Risk Stratification
2014
-
Double IGHV Gene Rearrangements in Chronic Lymphocytic Leukemia
2014
-
Effects of Sulforaphane Obtained from Broccoli Sprout Homogenate in Patients with Sickle Cell Disease (SCD)
2014
-
Empiric Definition of Eligibility Criteria for Clinical Trials in Relapsed/Refractory AML: Analysis of 1,892 Patients from HOVON/SAKK and SWOG
2014
-
Epigenetics of Cellular Memory: Insights from the Chromatin Accessibility Landscape of the Mitotic Genome
2014
-
Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model
2014
-
Favorable Outcomes for Older Adolescents and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL): Early Results of U.S. Intergroup Trial C10403
2014
-
Final Clinical Results with Laboratory Correlates in the Phase I Trial of Lenalidomide Plus Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)
2014
-
Genes Associated with Alloimmunization to Blood Group Antigens in Sickle Cell Disease
2014
-
Genes Associated with Survival in Adult Sickle Cell Disease
2014
-
Genome-Wide Association Study of Glomerular Filtration Rate in a Cohort of Sickle Cell Disease Patients
2014
-
Growing Pains - Determination of Transfer and Transition from Pediatrics to Adult Outpatient Clinics for Patients with Sickle Cell Disease (SCD)
2014
-
Growth Factor Receptor-Bound Protein 10 (Grb10) Regulates Hematopoietic Stem Cell Renewal
2014
-
Improved Outcomes of Autologous Hematopoietic Cell Transplantation (AHCT) for Light Chain (AL) Amyloidosis: A Center for International Blood and Marrow Transplant Registry (CIBMTR) Study
2014
-
Improved Survival in Patients with First Relapsed or Refractory Acute Myeloid Leukemia (AML) Treated with Vosaroxin Plus Cytarabine Versus Placebo Plus Cytarabine: Results of a Phase 3 Double-Blind Randomized Controlled Multinational Study (VALOR)
2014
-
Interim Analysis of a Phase 1 Trial of SGN-CD33A in Patients with CD33-Positive Acute Myeloid Leukemia (AML)
2014
-
Laboratory Assessment of Anti-Coagulant Properties of a Von Willebrand Factor Targeted Aptamer
2014
-
NF-kappa B Subunit c-Rel Cooperates with Myc and Mutated p53 to Confer Significantly Worse Survival in Patients with Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program
2014
-
Outcomes Following Allogeneic Stem Cell Transplantation (AlloSCT) in Patients with Primary Mediastinal (PMBL), Germinal Center B (GCB) and Non-GCB Cell-like Diffuse Large B Cell Lymphomas (DLBCL)
2014
-
Pan-Selectin Antagonist Rivipansel (GMI-1070) Reduces Soluble E-Selectin Levels While Improving Clinical Outcomes in SCD Vaso-Occlusive Crisis
2014
-
Pevonedistat (MLN4924), an Investigational, First-in-Class NAE Inhibitor, in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Considered Unfit for Conventional Chemotherapy: Updated Results from the Phase 1 C15009 Trial
2014
-
Phase II study of (90)y Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Marginal Zone Lymphoma
2014
-
Post-Transplant Cyclophosphamide Following Myeloablative Peripheral Blood Stem Cell Transplantation: A Single Institutional Experience
2014
-
Predicting the Temporal Course of Laboratory Abnormality Resolution in Patients with Thrombotic Microangiopathy
2014
-
Primary Treatment of Invasive Mucormycosis (IM) with Isavuconazole (VITAL Study) or Amphotericin Formulations (FungiScope (TM)): Case Matched Analysis
2014
-
Protein Tyrosine Phosphatase-Sigma (PTP sigma) Regulates Hematopoietic Stem Cell Repopulating Capacity
2014
-
Pyrvinium Selectively Targets Blast Phase Chronic Myeloid Leukaemia through Inhibition of Mitochondrial Respiration
2014
-
Screening for Neurocognitive Dysfunction in an Adult Population with Sickle Cell Disease
2014
-
Understanding the Underlying Immune Response in HIT: Uptake of PF4/Heparin Complexes By Monocytes & Dendritic Cells
2014
-
X-Ray Structure of an Anticoagulant RNA Aptamer Bound to Factor Xa. Structural Basis for Its Ability to Disrupt Interactions Between Xa and Va within Prothrombinase
2014
-
A Risk-Prediction Model For Identifying Venous Thromboembolism In Hospitalized Pediatric Patients: A Single Institution Retrospective Case-Control Analysis
2013
-
Alteration Of Cytogenetic Risk Stratification In New Diagnosis Of Leukemia By FISH Testing – Retrospective Review Of The SWOG Experience
2013
-
Azacitidine With Or Without Entinostat For The Treatment Of Therapy-Related Myeloid Neoplasm: Further Results Of The E1905 North American Leukemia Intergroup Study
2013
-
Clinical Experience Of Lenalidomide Plus Low Dose Dexamethasone As First-Line Therapy For Multiple Myeloma At a Large County Hospital Caring For An Indigent Population
2013
-
Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease
2013
-
Frontline-Treatment Of Acute Lymphoblastic Leukemia (ALL) In Older Adolescents and Young Adults (AYA) Using a Pediatric Regimen Is Feasible: Toxicity Results of the Prospective US Intergroup Trial C10403 (Alliance)
2013
-
GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease
2013
-
Humoral Immunity Induced By Viral Infection Provides a Major Barrier To Hematopoietic Cell Transplantation
2013
-
In Vivo Modeling Of Genetic Mechanisms Associated With Sickle Cell Disease Nephropathy
2013
-
MLN4924, a Novel Investigational Inhibitor Of NEDD8-Activating Enzyme (NAE), In Adult Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Results From Multiple Dosing Schedules In a Phase 1 Study
2013
-
MYC Mutation Profiling In 708 De Novo Diffuse Large B-Cell Lymphoma Demonstrates That Genetic Abnormalities In The Coding Sequence and Untranslated Regions Have Different Prognostic and Clinical Significance: A Report From The International DLBCL Rituximab-CHOP Consortium Program
2013
-
Molecular and Clinical Associations Between Vitamin D and Chronic Lymphocytic Leukemia
2013
-
NIH and National Foundation Expenditures For Sickle Cell Disease and Cystic Fibrosis Are Associated With Pubmed Publications and FDA Approvals
2013
-
Neutropenia In Glycogen Storage Disease 1b (GSD1b)
2013
-
OP449, a Novel SET Antagonist, Is Cytotoxic To Leukemia Cells and Enhances Efficacy Of Tyrosine Kinase Inhibitors In Drug-Resistant Myeloid Leukemias
2013
-
Outcomes Following Autologous Stem Cell Transplantation (ASCT) In Patients With Germinal Center B (GCB) and Non-GCB Cell-Like Diffuse Large B Cell Lymphomas (DLBCL) According To Conditioning With BEAM-Rituximab (Standard vs. High-Dose) Vs. BEAM/Yttrium-90 Ibritumomab Tiuxetan (90YIT)
2013
-
Palliative Care For Patients With Hematologic Malignancies: A Profile Of Patients With Blood Cancers Referred To The Choice Hospice Network
2013
-
Perceived Discrimination In Health Care Is Associated With Daily Chronic Pain In Sickle Cell Disease
2013
-
Phase 1 Study Of Investigational Agent MLN8237 (Alisertib) + Rituximab ± Vincristine In Patients (Pts) With Relapsed/Refractory (Rel/Ref) Aggressive B-Cell Lymphomas
2013
-
Pleiotrophin Improves Survival Following Radiation-Induced Myelosuppression and Mediates HSC Expansion Via Induction Of Ras Signaling
2013
-
Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program
2013
-
Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program
2013
-
Recruitment Of T Cells and Macrophages To The Eyes In Recipients Of Allogeneic Hematopoietic Stem Cell Transplants Correlate With Inflammatory Cytokine Presence In Ocular Gvhd
2013
-
STAT3 Expression and Clinical Implications In De Novo Diffuse Large B-Cell Lymphoma: A Report Fro The International DLBCL Rituximab-CHOP Consortium Program
2013
-
Sevuparin Reduces Adhesion Of Both Sickle Red Cells and Leukocytes To Endothelial Cells In Vitro and Inhibits Vaso-Occlusion In Vivo
2013
-
Targeting β-arrestin2 Enhances Survival in a Murine Model of Chronic Myeloid Leukemia
2013
-
A Genome-Wide Analysis of Variants Influencing Methotrexate Clearance Replicates SLCO1B1.
2012
-
A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502
2012
-
A Phase II Study of Elacytarabine/Idarubicin As Second Course Remission-Induction in Patients with Acute Myeloid Leukemia Who Failed Cytarabine/Anthracycline
2012
-
A Phase II Trial of Azacitidine (NSC-102816) and Gemtuzumab Ozogamicin (NSC-720568) As Induction and Post-Remission Therapy in Patients of Age 60 and Older with Previously Untreated Non-M3 Acute Myeloid Leukemia (SWOG S0703): Report On the Poor Risk Patients
2012
-
Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes
2012
-
An Institutional Experience: Correlation Between Absolute Lymphocyte Count and Survival Outcome After Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
2012
-
CD38 Variation in Chronic Lymphocytic Leukemia
2012
-
Declining Rates of Treatment-Related Mortality in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Given “Intensive” Induction Regimens: A Report From the Southwest Oncology Group (SWOG) and MD Anderson Cancer Center (MDA)
2012
-
Deficient ADAMTS13 Activity in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura (TTP) in Populations From Japan in 2012: Validation of Findings Initially Reported in the United States in 1998 and 2000.
2012
-
Describing Adherence to Recommended Preventative Care Behaviors Among Adults with Sickle Cell Disease
2012
-
Feasibility and Prognostic Value of VO2peak in Patients Undergoing Hematopoietic Cell Transplantation (HCT)
2012
-
Feasibility of Daily and Weekly Symptom and Health-Related Quality of Life (HRQOL) Surveillance in Patients Receiving Hematopoietic Cell Transplantation (HCT)
2012
-
Genetic Loss of Tmprss6 Increases Effective Erythropoiesis in a Mouse Model of beta-Thalassemia
2012
-
Genetic Loss of Tmprss6 Increases Effective Erythropoiesis in a Mouse Model of β-Thalassemia
2012
-
Genome-Wide Association Study Identifies Germline Polymorphisms Associated with Relapse of Childhood Acute Lymphoblastic Leukemia
2012
-
Genome-Wide Association Study Identifies a Novel Susceptibility Locus At 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethinically Diverse Populations
2012
-
High Incidence of Antibodies to Protamine and Protamine/Heparin Complexes in Patients Undergoing Cardiopulmonary Bypass
2012
-
High Incidence of Antibodies to Protamine and Protamine/Heparin Complexes in Patients Undergoing Cardiopulmonary Bypass
2012
-
ID3 Is a Novel Tumor Suppressor Gene in Burkitt Lymphom
2012
-
Long Term Outcomes of Hematopoietic Stem Cell Transplantation in Patients with Severe Phenotype Hurler Syndrome: an International Multi-Center Study
2012
-
Modeling Variation in the Human Lymphoma Microenvironment with the E mu-Myc Mouse Model
2012
-
No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial
2012
-
No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial
2012
-
Novel Techniques for Measurement of Variable Sized PF4/H Complexes.
2012
-
Outcome of Transplantation for Acute Leukemia in Down Syndrome
2012
-
PF4/H Complexes Induce Germinal Centers in Vivo
2012
-
Pan-Selectin Antagonist GMI-1070 Affects Biomarkers of Adhesion, Activation and the Coagulation Cascade in Sickle Cell Adults At Steady State
2012
-
Partial Reversal of Dabigatran Effect by a Prothrombin Complex Concentrate in a Model of Thrombin Generation
2012
-
Peripheral Blood gamma delta T Cell Response to High-Grade Glioma: Implications for Localized Adoptive Immunotherapy
2012
-
Peripheral Blood γδ T Cell Response to High-Grade Glioma: Implications for Localized Adoptive Immunotherapy
2012
-
Phase 1 Study of Lenalidomide and Decitabine for High and Intermediate 2 Risk MDS
2012
-
Phase II Study of VEGF Inhibitor, PTK787/ZK222584, in Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma
2012
-
Pilot Study of Sorafenib for Myelodysplastic Syndrome
2012
-
Polycythemia Vera and Chronic Idiopathic Myelofibrosis CD34+ Cells Preferentially Traffic to Splenic Niches
2012
-
Proteomic Analysis of ERK1/2-Mediated Human Sickle Red Blood Cell Membrane Protein Phosphorylation.
2012
-
Results From the Dose Escalation Phase of a Randomized Phase 1–2 First-in-Human (FIH) Study of SGI-110, a Novel Low Volume Stable Subcutaneous (SQ) Second Generation Hypomethylating Agent (HMA) in Patients with Relapsed/Refractory MDS and AML
2012
-
Results of a Large Prospective Study On the Use of Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome – Updated Results of a Treatment IND (T-IND) Expanded Access Protocol
2012
-
SL-401, A Targeted Therapy Directed to the Interleukin-3 Receptor Present On Leukemia Blasts and Cancer Stem Cells, Is Active As a Single Agent in Patients with Advanced AML
2012
-
Surgical Mask Usage Reduces the Incidence of Parainfluenza Virus 3 in Recipients of Stem Cell Transplantation
2012
-
Surgical Mask Usage Reduces the Incidence of Parainfluenza Virus 3 in Recipients of Stem Cell Transplantation
2012
-
The Metabolic Signature of CLL: Enhanced Glucose Metabolism in A Subset of High-Risk CLL Patients
2012
-
Therapeutic Benefit of Small Molecule Inhibitors of MEK/ERK in Reducing Sickle Red Cell Adhesion and Vaso-Occlusion in Vivo
2012
-
Therapeutic Benefit of Small Molecule Inhibitors of MEK/ERK in Reducing Sickle Red Cell Adhesion and Vaso-Occlusion in Vivo
2012
-
Timing of the Initiation of Hydroxyurea and Hematologic Outcomes in Patients with Sickle Cell Disease (SCD)
2012
-
Updated Analysis of a Prospective Phase II Trial of R-MACLO-IVAM Followed by Maintenance for Mantle Cell Lymphoma
2012
-
Using High-Throughput Sequencing of Red Blood Cells and Platelets to Identify Micrornas Associated with Hematopoiesis.
2012
-
A Common Deletion Polymorphism in the BIM Gene Contributes to Intrinsic Imatinib Resistance in Chronic Myelogenous Leukemia
2011
-
A Novel SET Antagonist (OP449) Is Cytotoxic to CML Cells, Including the Highly-Resistant BCR-ABLT315I Mutant, and Demonstrates Enhanced Efficacy in Combination with ABL Tyrosine Kinase Inhibitors,
2011
-
A Phase II Prospective Feasibility Study of Clofarabine Cytoreduction Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Relapsed or Refractory Acute Leukemias and Advanced Myelodysplastic Syndromes
2011
-
A Phase II Study of Elacytarabine/Idarubicin As Second Course Remission-Induction in Patients with Acute Myeloid Leukemia Who Failed Cytarabine/Anthracycline, and Evaluation of the Impact of the Nucleoside Transporter hENT1 on Response
2011
-
ASXL1 Mutations Identify a High-Risk Subgroup of Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia within the European LeukemiaNet 'Favorable' Genetic Category
2011
-
An Elevated Tricuspid Regurgitant Jet Velocity in Sickle Cell Disease Is Associated with Polymorphisms in Genes Impacting Innate Immunity
2011
-
Biomarkers of Hemostatic Activation in a Randomized, Double-Blind, Phase 2 Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease
2011
-
CPX-351: A Randomized Phase 2b Study of CPX-351 v. Intensive Salvage Therapy in '65 Yo First Relapse AML Patients: Initial Efficacy and Safety Report
2011
-
Characterization of Pim Protein Kinases and Evaluation of Small Molecule Inhibitors in Multiple Myeloma
2011
-
Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost
2011
-
Chronic Lymphocytic Leukemia Shares a Common Cellular Origin with Regulatory B10 Cells
2011
-
Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol
2011
-
Development of a Quality of Life Instrument Specific for Cutaneous Lymphoma
2011
-
Differences in Stem Cell Collection Practices and Related Outcomes Between Centers That Conduct and Do Not Conduct Aphaeresis on Weekends
2011
-
Genomic Heterogeneity in B-Cell Malignancies
2011
-
HIT Antibody Seropositivity and Thromboembolic Events After Cardiac Surgery
2011
-
High Complete Response Rates with Dose Dense/Dose Intense Chemotherapy Plus Radioimmunotherapy in High Risk Diffuse Large B Cell and Mantle Cell Lymphoma
2011
-
High Dose BCNU/Melphalan Preparative Regimen Doubles Event Free Survival of Myeloma Patients Undergoing Autologous Transplantation
2011
-
Hijacking the Niche: The Role of Stromal Osteopontin in the Induction of Leukemic Dormancy within the Bone Marrow Microenvironment
2011
-
Impact of High Dose Cyclophosphamide on the Outcome of Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma
2011
-
Inflammatory Polymorphisms Link the Risk of Acute Chest Syndrome with Asthma in Adults with Sickle Cell Disease
2011
-
MiR-3151, a Novel MicroRNA Embedded in BAALC, Is Only Weakly Co-Expressed with Its Host Gene and Independently Impacts on the Clinical Outcome of Older Patients (Pts) with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)
2011
-
Personalizing Cancer Supportive Care: Predicting Neutropenic Complications in Patients Receiving Intermediate Risk Cancer Chemotherapy
2011
-
Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2)
2011
-
Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures
2011
-
Prevalence of MBL Increases Over Time In Relatives of CLL Families
2011
-
Prognostic Significance of FLT3 and NPM1 Mutations in Adults of Age 18-60 with De Novo Acute Myeloid Leukemia (AML) on SWOG S0106 Study: A Study by FHCRC and SWOG
2011
-
Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts)
2011
-
Prognostic Value of cMYC Gene Abnormalities in Diffuse Large B Cell Lymphoma Treated with Chemo-Immunotherapy
2011
-
Race As a Determinant of Disease Biology and Outcomes in Chronic Lymphocytic Leukemia
2011
-
Re-Induction Therapy Decisions Based on Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia
2011
-
Referral Patterns and Outcomes for Women with for Recurrent Pregnancy Loss Managed At a Multidisciplinary Thrombosis Program
2011
-
Relationships Among Commonly Used Measures of Cord Blood Potency, ALDH(br) Cell Content, and Colony Forming Cell Content in Cord Blood Units Prior to Cryopreservation: Towards An Improved Metric for Potency of Banked Cord Blood
2011
-
Results of the OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia
2011
-
Safety and Tolerability of Plerixafor in Combination with Cytarabine and Daunorubicin in Patients with Newly Diagnosed Acute Myeloid Leukemia-Preliminary Results From a Phase I Study
2011
-
Sickle Red Blood Cell Induced Adhesion of Neutrophils to Endothelial Cells and Biologic Correlates of Leukocyte Activation
2011
-
Significance of Prior HSCT on the Outcome of Salvage Therapy with CPX-351 or Conventional Chemotherapy Among First Relapse AML Patients
2011
-
Sirolimus Inhibits Proliferation but Enhances Suppressive Activity of Rhesus Macaque Natural CD4 Regulatory T Cells
2011
-
Tandem HLA-Mismatched Cadaveric Unrelated Donor Lung Transplant Followed by CD3-and CD19-Depleted Bone Marrow Transplant From the Same Donor Permits Withdrawal of Systemic Immunosuppression with Graft Acceptance and Functional Immune Reconstitution
2011
-
The Impact of Factor IX Level on Thrombin Generation and Bleeding During Warfarin Anticoagulation
2011
-
The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation
2011
-
The Role of Surface Immunoglobulin Isotype in Chronic Lymphocytic Leukemia Disease Biology and Clinical Outcome
2011
-
The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study
2011
-
Transient Decrease in Factor VIII Following Delivery: Clearance or Consumption?
2011
-
Variation in Health-Related Quality of Life (HRQOL) Among Multiple Myeloma Patients by Insurance Coverage
2011
-
Vorinostat in Combination with Pegylated Liposomal Doxorubicin (PLD) and Bortezomib (B) in Patients with Relapsed/Refractory Multiple Myeloma (R/R MM): Final Results of a Phase I Study
2011
-
What Clinical Characteristics of Mothers and Babies Favorably Influence Cord Blood Potency? Defining Parameters That Can Guide Public Cord Blood Collection
2011
-
Whole Genome and Exome Sequencing Reveals the Genetic Landscape of Burkitt Lymphoma
2011
-
Whole-Exome Sequencing Identifies Novel Risk Variant for Thrombotic Storm
2011
-
A 10 Day Schedule of Azacitidine Induces More Complete Cytogenetic Remissions Than the Standard Schedule In Myelodysplasia and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the E1905 US Leukemia Intergroup Study
2010
-
A Comprehensive Comparison Immune Recovery In Adult Patients Following Allogeneic Umbilical Cord Blood, Matched Sibling and Matched Unrelated Donor Stem Cell Transplantation
2010
-
A Novel Scoring System, the Cord Blood Apgar, Predicts Engraftment After Cord Blood Transplantation: Optimization of Selection of Cord Blood Units (CBUs) for Transplantation
2010
-
A Phase I/II Trial of the Potent Hsp90 Inhibitor STA-9090 Administered Once Weekly In Patients with Advanced Hematologic Malignancies
2010
-
A Randomized Trial of the Safety and Benefit of Transfusion Vs. Standard Care In the Prevention of Sickle Cell-Related Complications In Adults: a Preliminary Report From the Phase II NHLBI Comprehensive Sickle Cell Centers (CSCC) Study of Neuropsychological Dysfunction and Neuroimaging Abnormalities In Neurologically Intact Adult Patients with Sickle Cell Disease
2010
-
A Retrospective Multi-Center Analysis of Prognostic Factors Determining Outcomes In Patients with Secondary AML.
2010
-
ARID5B Genetic Polymorphisms Contribute to Racial Disparities In Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
2010
-
Allogeneic Effector Memory T Cells Enhance Hematopoietic Engraftment and Immune Reconstitution After Stem Cell Transplantation
2010
-
Allogeneic Hematopoietic Stem Cell Transplantation with Clofarabine/Busulfan × 4 (CloBu4) Conditioning Exhibits Significant Anti-Tumor Activity In Non - Remission Hematologic Malignancies, Especially In AML
2010
-
Alternative Splicing Is a Major Mechanism of Gene Regulation In Diffuse Large B Cell Lymphoma
2010
-
An Ear-Tissue Model for High-Resolution In Vivo Imaging.
2010
-
Analysis of Risk Factors Influencing Outcomes After Unrelated Cord Blood Transplantation In Children with Juvenile Myelomonocytic Leukemia. An Eurocord, EBMT, EWOG-MDS, CIBMTR Study
2010
-
Anti-Inflammatory Markers Are Associated with Glomerular Filtration Rate In Adults with Sickle Cell Disease
2010
-
Atypical Activation of Plasma Membrane-Bound ERK1/2 Is Associated with Regulation of Sickle Red Cell Adhesion to Endothelium
2010
-
Chronic Graft-Versus-Host Disease and Its Association with Treatment-Related Mortality, Relapse, Leukemia-Free and Overall Survival After Umbilical Cord Blood Transplantation (UCBT) In Children and Adolescents with Acute Leukemia
2010
-
Dasatinib Versus Imatinib In Patients with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP) In the DASISION Trial: 18-Month Follow-up
2010
-
Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF): Results of a Treatment IND Expanded Access Protocol
2010
-
Dendritic Cell Activation by PF4/H Multimolecular Complexes
2010
-
Disruption of PF4/Hep Multimolecular Complex Assembly Using a Minimally Anticoagulant Heparin (ODSH)
2010
-
Donor Cell Leukemia: A Clinicopathological Study of 9 Cases and a Comprehensive Review of Literature
2010
-
Efficacy and Safety of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil (R)) plus G-CSF In Adult Patients with Non-Hematologic Malignancies.
2010
-
Efficacy and Toxicity of Rituximab and Brief Duration, High Intensity Chemotherapy with Filgrastim Support for Burkitt or Burkitt - Like Leukemia/Lymphoma: Cancer and Leukemia Group B (Calgb) Study 10002
2010
-
Efficacy of Denileukin Diftitox Retreatment In Patients with Cutaneous T-Cell Lymphoma Who Relapsed After Initial Response
2010
-
Facilitation of Hematopoietic Reconstitution Via Inhibition of Bone Marrow Endothelial Cell-Mediated SDF-1 Signaling
2010
-
Factors Associated with Heterocellular Aggregate Formation In Sickle Cell Disease.
2010
-
GMI-1070, a Pan-Selectin Inhibitor: Safety and PK In a Phase 1/2 Study In Adults with Sickle Cell Disease.
2010
-
Genetic Variation In MYH9 Is Associated with Sickle Cell Disease Nephropathy
2010
-
Heparin Modifies the Immunogenicity of Positively-Charged Proteins
2010
-
Hepcidin as a Therapeutic Tool to Limit Iron Overload and Improve Anemia In beta-Thalassemia
2010
-
Hydroxyurea Induces Genome-Wide Epigenetic Changes In Sickle Cell Disease
2010
-
Hydroxyurea Reduces Conversion From Conditional to Abnormal TCD Velocities In Children with Sickle Cell Anemia (SCA)
2010
-
Identification of Thrombospondin-1 and L-Selectin as Potential Plasma Biomarkers of Silent Cerebral Infarct In Children with Sickle Cell Disease Using a Proteomic-Based Approach
2010
-
Identification of a Costimulation Blockade Resistant Mechanism of Bone Marrow Allograft Rejection Induced by Infection with a Murine EBV Homologue.
2010
-
Increased Platelet Binding of NN1731, a Factor VIIa Variant with Enhanced Tissue Factor-Independent Activity
2010
-
Initial Experience with the IMPROVE Trial-a Phase III Analgesic Trial for Hospitalized Sickle Cell Painful Episodes
2010
-
Investigation of CLL-Susceptibility Loci with Monoclonal B-Cell Lymphocytosis (MBL) Risk and Confirmation of Recently Reported CLL-Susceptibility Loci
2010
-
Long-Term Follow-up of Adults with Severe Sickle Cell Disease After Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning
2010
-
Meta-Analysis of Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) with Comparison to a Historical Control (HC)
2010
-
Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study
2010
-
Overall Survival of Lymphoma Patients In Randomized Controlled Trials Comparing Primary G-CSF Chemotherapy Support to Control
2010
-
Phase 3 Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin Lymphoma (EXTEND): End of Study Results
2010
-
Phase I Trial Results for SL-401, a Novel Cancer Stem Cell (CSC) Targeting Agent, Demonstrate Clinical Efficacy at Tolerable Doses In Patients with Heavily Pre-Treated AML, Poor Risk Elderly AML, and High Risk MDS
2010
-
Pleiotrophin Signaling Is Necessary and Sufficient for Hematopoietic Stem Cell Self-Renewal In Vivo
2010
-
Post-Transplant Lymphoproliferative Disease In Liver Transplant Recipients: A Single Institution Experience
2010
-
Pre-Clinical and Interim Results of a Phase II Trial of Perifosine In Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
2010
-
Pregnancy In Type 1 Von Willebrand Disease: A Prospective Study of VWF Levels and Risk Factors for Bleeding.
2010
-
Prolonged Administration of Azacitidine with or without Entinostat Increases Rate of Hematologic Normalization for Myelodysplastic Syndrome and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905
2010
-
Prospective, Biological Randomized Study of T-Cell Depleted Nonmyeloablative Allogeneic Transplantation From HLA-Matched Related, Unrelated or Haploidentical Donors for Patients with Hematologic Malignancies.
2010
-
Reduced Intensity Conditioning In Children Undergoing Unrelated Umbilical Cord Blood Transplantation for Non-Malignant Diseases: Preliminary Results Demonstrate a High Rate of Engraftment and Low Incidence of Gvhd.
2010
-
Relationship of Race/Ethnicity and Survival After Single Umbilical Cord Blood Transplantation
2010
-
Relationship of Soluble Adhesion Receptors to Red Cell Apoptosis In SCD
2010
-
Results of a Phase I Study of Vorinostat In Combination with Pegylated Liposomal Doxorubicin and Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma
2010
-
S-Nitrosylation of Rap1and Relationship to Rap1 Activity and Disease Status In SCD
2010
-
Six Year, Single Institution, off-Label Use of Recombinant Factor VIIa.
2010
-
Targeting Destruction of Mcl-1 by Activation of Protein Phosphatase 2A In CLL and B-Cell Lymphomas
2010
-
The Molecular Profile of Richter Syndrome Predicts Survival From Transformation: The Role of Clonal Relationship
2010
-
The Novel, Investigational NEDD8-Activating Enzyme Inhibitor MLN4924 In Adult Patients with Acute Myeloid Leukemia (AML) or High-Grade Myelodysplastic Syndromes (MDS): A Phase 1 Study
2010
-
The Serine Protease Tmprss6 Regulates Hepcidin Expression, but Its Loss Does Not Cause Systemic Iron Deficiency In the Fetal and Neonatal Periods
2010
-
Tmprss6, An Inhibitor of Hepatic Bmp/Smad Signaling, Is Required for Hepcidin Suppression and Iron Loading In a Mouse Model of beta-Thalassemia
2010
-
Transfusion Requirements and Outcomes In the Cohort of Patients Undergoing-Isolated CABG Treated with Prasugrel or Clopidogrel: TRITON-TIMI 38 Data Analysis
2010
-
VE Cadherin Positive Endothelial Cells Regulate Hematopoietic Reconstitution In Vivo
2010
-
Validation of the Cord Blood (CB) APGAR Score System to Predict Neutrophil Engraftment of Plasma Depleted CB Products
2010
-
A Comprehensive Identification of the Microrna Transcriptome and Its Application in B Cell Malignancies
2009
-
A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia
2009
-
A Phase II Multicentre Study with Elacytarabine as Second Salvage Therapy in Patients with AML.
2009
-
ALDH(br) Hematopoietic Progenitors Promote Short-Term Engraftment in Experimental Models for Cord Blood Transplantation.
2009
-
Acute Myeloid Leukemia or Myelodysplastic Syndromes and All-Cause Mortality in Randomized Controlled Trials of Cancer Patients Receiving Chemotherapy with or without Granulocyte Colony-Stimulating Factor: A Systematic Review and Meta-Analysis
2009
-
Allospecific Effector Memory T Cells Are Able to Mediate Second-Set Skin Graft Rejection but Unable to Induce Graft-Versus-Host Disease
2009
-
Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study.
2009
-
Cenersen, An Antisense Inhibitor of p53, in Combination with Fludarabine, Cyclophosphamide, and Rituximab Shows Clinical Activity in High Risk CLL.
2009
-
Characterization of Receptors Involved in Heparin Antibody Complex Mediated Induction of Tissue Factor Expression in Monocytes
2009
-
Comparison of Thrombin Generation of Sickle Cell Patients in Microparticle Rich and Microparticle Poor Plasma Using Thrombin Generation Assay (TGA).
2009
-
Complete Response to Clofarabine Is Durable and Correlates with Survival in Previously Untreated Older Adult Patients with Acute Myeloid Leukemia (AML) and Unfavorable Prognostic Factors
2009
-
Creation of a Segment-Based Aldehyde Dehydrogenase Assay as a Biomarker for Cord Blood Potency.
2009
-
Defibrotide (DF) in the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) Following Stem Cell Transplantation (SCT): Results of a Phase 3 Study Utilizing a Historical Control
2009
-
Deletion of Bak and Bax in Tie2+BM Hematopoietic Stem Cells Induces a B Cell Lymphoproliferative Disorder
2009
-
Development of a Decision Support Tool to Guide Management of Adults with Sickle Cell Disease: The Emergency Department Sickle Cell Assessment of Strengths and Needs (ED-SCANS).
2009
-
Effect of PAI-1 Specific RNA Aptamers On Cell Adhesion and Motility
2009
-
Effects of Hydroxyurea (HU) and Magnesium Pidolate (Mg) in Hemoglobin SC Disease (HbSC): the "CHAMPS" Trial
2009
-
Efficacy and Safety of Nilotinib in Elderly Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A Sub-Analysis of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study
2009
-
Family-Associated Monoclonal B Lymphocytosis Shows Differences From CLL That Suggest An Indolent Biology
2009
-
Gene Expression Profiling Reveals 5-Azacytidine to Be a Novel, Potentially Effective Therapy for Poor-Prognosis Patients with Multiple Myeloma
2009
-
Genetic Polymorphisms in NEDD4L Are Associated with Pulmonary Hypertension of Sickle Cell Anemia.
2009
-
Genome-Wide Analysis of Microdeletions and Identification of NF1 Inactivation in Acute Myelogenous Leukemia.
2009
-
Genome-Wide Studies in Sickle Cell Anemia Show Associations Between SNPs in the Olfactory Receptor Gene Cluster and Fetal Hemoglobin Concentration
2009
-
Heparin Forms Macromolecular Complexes with Protamine and Lysozyme.
2009
-
Histone Deacetylase Inhibition Using LBH589 Is Effective in Lymphoma and Results in Down-Regulation of the NF-KB Pathway
2009
-
Immunocompromised Status of Patients with Hematologic and Solid Tumor Malignancies: Construction of a Practical Algorithm
2009
-
Impact of Nucleated Cell Dose On Engraftment and Survival After Unrelated Cord Blood Transplantation for Severe Aplastic Anemia: A Retrospective Study On Behalf of Eurocord and the EBMT SAA WP
2009
-
Impact of Prior Therapy and Suboptimal Response to Imatinib On the Efficacy and Safety of Nilotinib Among 1,422 Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): Sub-Analyses of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study
2009
-
In-Hospital Outcomes Among Sickle Cell Patients with Acute Chest Syndrome: Results From a National Database.
2009
-
Increased Severity of Pandemic H1N1 Influenza in Children and Young Adults with Sickle Cell Disease
2009
-
Influence of Statin Therapy On the Clinical Course of Chronic Lymphocytic Leukemia
2009
-
Long-Term Survival and Late Deaths After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency Diseases and Inborn Errors of Metabolism
2009
-
Loss of Function of the VHL Tumor Suppressor Gene Resurrects An Endogenous Retrovirus in Kidney Cancer That Encodes a Tumor Antigen Targeted by Allogeneic T-Cells Following Hematopoietic Cell Transplantation (HCT)
2009
-
Low Levels of Apolipoprotein A1 Are Associated with Silent Cerebral Infarets in Children with Sickle Cell Disease
2009
-
Maintenance Therapy with Low-Dose Subcutaneous 5-Azacitidine in Older Patients with AML in 1st Remission.
2009
-
Melphalan and Dexamethasone Plus Bortezomib Induces Hematologic and Organ Responses in AL-Amyloidosis with Tolerable Neurotoxicity
2009
-
Molecular Profiling Identifies Plasmablasts as the Cells of Origin of Activated Diffuse Large B Cell Lymphoma
2009
-
Monosomal Karyotype Is Predictive of Poor Response to Therapy and Worse Overall Survival in Secondary Acute Myeloid Leukemia (sAML); Analysis of a Multi-Center Phase II Study of Amonafide and Cytarabine Induction Therapy.
2009
-
Nilotinib Responses and Tolerability Confirmed in North American Patients with Chronic Myeloid Leukemia (CML) From ENACT (Expanding Nilotinib Access in Clinical Trials)
2009
-
Overexpression and Phosphorylation of eIF4E Is Required for Beta-Catenin Activation in Blast Crisis Chronic Myelogenous Leukemia
2009
-
PI3K Inhibitors Inhibit Lymphoma Growth by Downregulation of MYC-Dependent Proliferation.
2009
-
Patterns and Management of Selected Adverse Events of Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) From the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.
2009
-
Phase II Study of the Oral MEK Inhibitor AZD6244 in Advanced Acute Myeloid Leukemia (AML).
2009
-
Physiologic Hypoxia Protects Chronic Myelogenous Leukemia Progenitors From Elimination by Imatinib Mesylate
2009
-
Plerixafor (Mozobil (R)) Selectively Enhances Donor Hematopoietic Cell Engraftment
2009
-
Polymorphisms in TNFα Are Associated with Cerebrovascular Events in Sickle Cell Disease.
2009
-
Pralatrexate Induces Responses in Patients with Highly Refractory Peripheral T-Cell Lymphoma (PTCL).
2009
-
Preliminary Results of Southwest Oncology Group Study S0106: An International Intergroup Phase 3 Randomized Trial Comparing the Addition of Gemtuzumab Ozogamicin to Standard Induction Therapy Versus Standard Induction Therapy Followed by a Second Randomization to Post-Consolidation Gemtuzumab Ozogamicin Versus No Additional Therapy for Previously Untreated Acute Myeloid Leukemia
2009
-
Prevention of Acute GvHD During MHC Haploidentical BMT: Evaluating the Efficacy of T-Cell Costimulation Blockade Using a Novel Rhesus Macaque Transplant Model.
2009
-
Proteomic-Based Approach for Biomarker Discovery to Predict Silent Cerebral Infarct in Patients with Sickle Cell Disease
2009
-
Racial Differences in Thrombotic Risk Factors Associated with Adverse Pregnancy Outcome Among Women Obtaining Care in US Thrombosis and Hemostasis Centers
2009
-
Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse
2009
-
Retrospective Review of the Natural History of Pulmonary Hypertension in Sickle Cell Disease Demonstrates That Progressive Enlargement of the Left Atrium Is a Strong Predictor of Death.
2009
-
Single-Agent Clofarabine Produces Durable Remissions in Patients with Acute Myelogenous Leukemia (AML) Who Are >= 70, Have Intermediate or Unfavorable Cytogenetics, Antecedent Hematological Disorders (AHD), or 2 or More Unfavorable Prognostic Factors
2009
-
Systemic Administration of Pleiotrophin Induces Hematopoietic Stem Cell Regeneration In Vivo.
2009
-
The Anti-Inflammatory Investigational Agent LMP-420 Demonstrates in Vitro Cytotoxic Activity against Chronic Lymphocytic Leukemia Cells
2009
-
The Complex Relationship Between Sickle Cell Disease and Depression
2009
-
The SET Oncogene, a Potent PP2A Inhibitor, Is Elevated in CLL and Antagonism of SET Induces Apoptosis.
2009
-
Thienopyridine-Associated Thrombotic Thrombocytopenia Purpura: Updated Antibody Results From the SERF-TTP Study
2009
-
Thymic Recovery and De Novo T Cell Production During the First Year After Unrelated Cord Blood Transplant (UCBT) Predicts Overall Survival: A Multivariate Analysis of 93 Patients Following Myeloablative Conditioning and a Single Unit Graft.
2009
-
Tie2+Bone Marrow Endothelial Cells Regulate Hematopoietic Reconstitution In Vivo
2009
-
Tmprss6 Is a Genetic Modifier of the Hfe-Hemochromatosis Phenotype in Mice
2009
-
Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources
2009
-
Use of Aldehyde Dehydrogenase Content to Predict Dominating Cord in Double Cord Blood Transplant
2009
-
Use of a Computer Based Neurocognitive Software Program in Asymptomatic Neurologically Intact Adults with Sickle Cell Disease.
2009
-
Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study
2009
-
Biologic Prognostic Markers in Diffuse Large B-Cell Lymphoma Patients Treated with Dose Adjusted EPOCH-R: a CALGB 50103 Correlative Science Study
2008
-
Comprehensive Ultra High Resolution Analysis of Copy Number and Allele Status Including Novel Microdeletions Spanning NF1 in Acute Myelogenous Leukemia
2008
-
Distinct Mechanisms of Idiopathic and Thienopyridine-Assocaited Thrombotic Thrombocytopenia Purpura: Final Results from the Surveillance, Epidemiology, and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) Study
2008
-
Durable Responses in Patients Treated with Galiximab (Anti-CD80) in Combination with Rituximab for Relapsed or Refractory Follicular Lymphoma: Long-Term Follow-up of a Phase II Clinical Trial.
2008
-
Final Risk Prediction Model for Neutropenic Complications in Patients Receiving Cancer Chemotherapy
2008
-
Identification of p53 Aberration-Dependent as Well as Non-p53-Mediated Resistance to MDM2 Inhibitors in Acute Myelogenous Leukemia
2008
-
Insulin-Like Growth Factor 1 Protects against Lethal Irradiation.
2008
-
Myeloablative Conditioning with Clofarabine and Busulfan X 4 (CloBu4) Is Well Tolerated, Facilitates Secure Engraftment, and Exhibits Significant Anti-Tumor Activity against Non-Remission Hematologic Malignancies Including AML
2008
-
Phase II Study of Single Agent Clofarabine in Previously Untreated Older Adult Patients with Acute Myelogenous Leukemia (AML) Unlikely to Benefit from Standard Induction Chemotherapy
2008
-
Prevention of Acute GvHD during Haplo-BMT: Evaluating the Efficacy of T-Cell Costimulation Blockade Using a Novel Rhesus Macaque Transplant Model
2008
-
Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II MultiCenter EVOLUTION Study
2008
-
Single Donor 4/6 Matched Banked Unrelated Cord Blood Is An Effective Graft Source for Children Undergoing Myeloablative Transplantation for Malignant and Nonmalignant Disorders: Single Center Analysis of 318 Patients
2008
-
Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome
2008
-
Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome: Results of a Randomized Comparative Phase III Study
2008
-
A Genomic Strategy To Refine Prognosis and Predict Response to Therapy in Chronic Lymphocytic Leukemia.
2007
-
A conditional risk model for chemotherapy-induced anemia (CIA) in cancer patients.
2007
-
Allogeneic Committed Hematopoietic Progenitors Are Protective Against Radiation.
2007
-
Analysis of the Cellular Components of the Graft and Clinical Characteristics of 159 Children with Lysosomal and Peroxisomal Disorders (LSD) Undergoing Unrelated Umbilical Cord Blood Transplantation at a Single Center.
2007
-
Apolipoprotein E (APOE) Genotype as a Determinant of Survival in Women with Chronic Lymphocytic Leukemia.
2007
-
Avoidance of post-thaw wash prior to transplantation of plasma depleted cord blood (PD CB) is associated with improved engraftment & decreased severity of chronic GvHD (cGvHD) without increased relapse
2007
-
Blocking adhesion of sickle erythrocytes to endothelial P-selectin using an RNAaptamer
2007
-
Clinical and outcomes findings for thrombotic thrombocytopenic purpura among 467 persons with severely versus not severely deficient ADAMTS13 levels
2007
-
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia
2007
-
Cytotoxicity of the Type 4 Phosphodiesterase Inhibitor CD160130 for Freshly Isolated Human CLL Cells In Vitro.
2007
-
Dynamic In Vivo Imaging Reveals That Leukemia-Induced Changes in the Bone Marrow Microenvironment Alter Mechanisms of Metastasis.
2007
-
Efficacy of Hydroxyurea To Prevent Organ Damage in Young Children with Sickle Cell Anemia.
2007
-
Functional and Numerical T Cell Abnormalities in Chronic Lymphocytic Leukemia.
2007
-
Further investigation of the role of factor XIII in priapism associated with SCD
2007
-
Genomic complexity identifies patients with agressive chronic lymphocytic leukemia.
2007
-
Inhibition of nitric oxide synthase (NOS) 1, NOS2, and NOS3 enzymatic activities by vitamin B-12 and related corrins: Biochemical and molecular modeling studies
2007
-
Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14 with differential expression of LATS2
2007
-
MicroRNA expression in red blood cells from patients with PNH
2007
-
Monoclonal B Cell Lymphocytosis Exhibits Biologic Diversity Similar to Chronic Lymphocytic Leukemia.
2007
-
Monoclonal B Cell Lymphocytosis as a Marker of Inherited Predisposition to Chronic Lymphocytic Leukemia.
2007
-
Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients
2007
-
Phase I Study Demonstrates Activity and Tolerability of Diphtheria Toxin Interleukin-3 Fusion Protein in Patients with AML and MDS.
2007
-
Phase II Studies of Different Schedules and Doses of the Farnesyl Transferase Inhibitor Tipifarnib (R115777, Zarnestra, NSC-702818) for Patients of Age 70 or Older with Previously Untreated Acute Myeloid Leukemia (AML): A North American Intergroup Study (S0432).
2007
-
Post Thaw Colony Forming Units (CFU) Is a Strong Independent Predictor of Engraftment after Unrelated Donor Umbilical Cord Blood Transplantation (UCBT).
2007
-
Post Transplant Autoimmune Hemolytic Anemia and Other Cytopenias Are Increased in Very Young Babies after Unrelated Donor Umbilical Cord Blood Transplantation.
2007
-
Prediction of Heparin Induced Thrombocytopenia: Validation of an Experience-Based Computer Model.
2007
-
Predictors of In-Hospital Mortality and Charges in Sickle Cell Disease: Results from the California Discharge Databases 1998–2005.
2007
-
Risk Factor Analysis of Outcomes after Unrelated Cord Blood Transplantation for Children with Hurler’s Syndrome. An Eurocord-Duke University Collaborative Study.
2007
-
Sickle RBCs stimulate human monocyte cytokine expression
2007
-
Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-incluced mobilization
2007
-
The Effects of Chronic Opiates Pain Therapy in Sickle Cell Anemia.
2007
-
The relationship of opiate analgesia to quality of life in an adult sickle cell population
2007
-
Use of Mesenchymal Stem Cells To Treat Pediatric Patients with Severe (Grade III–IV) Acute Graft Versus Host Disease Refractory to Steroid and Other Agents on a Compassionate Use Basis.
2007
-
A Phase I Study of Cloretazine® and Temozolomide in Patients with Hematologic Malignancies.
2006
-
A Phase II Trial of Combination Therapy with Arsenic Trioxide (ATO) and Gemtuzumab Ozogamicin (GO) in Patients with High-Risk Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML) Arising from MDS.
2006
-
Acute Graft Versus Host Disease (GVHD) Is Increased in Patients Receiving Cyclosporine/Cellcept as Frontline Prophylaxis Against GVHD in Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation.
2006
-
Adult Umbilical Cord Blood Transplantation Following Non-Myeloablative Conditioning; Impact of Increased Cell Dose and 200cGy TBI on Engraftment and Survival.
2006
-
Antiproliferative Activity of ELACYT™ (CP-4055) in Combination with Cloretazine (VNP40101M), Idarubicin or Gemcitabine in HL-60 Human Myeloid Leukemia Cells.
2006
-
Changes in the pattern of cytogenetic aberrations with advancing age in acute myeloid (Non-APL) leukemia: A Southwest Oncology study (S9007).
2006
-
Coagulopathy from severe postpartum hemorrhage.
2006
-
Cost-Effectiveness of Posaconazole Versus Standard Azole Therapy in the Prevention of Invasive Fungal Infections among High-Risk Neutropenic Patients in the U.S.
2006
-
Current prevalence of specific clinical outcomes in adult patients with HbSS or Hb S beta(0) thalassemia.
2006
-
Defects in E2F1/2 expression are associated with abnormalities in cell cycle and differentiation in EKLF-deficient erythroid cells.
2006
-
Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial.
2006
-
Determinants of PF4/heparin immunogenicity in a murine model of HIT.
2006
-
Dosing of Post-Thaw Colony Forming Units (CFU) and CD34 Cells Predict Engraftment and Survival in Recipients of Banked Unrelated Donor Umbilical Cord Blood (UCB) for Allogeneic Transplantation.
2006
-
Effect of single dose in vivo propranolol therapy on in vitro adhesion of human SS RBC.
2006
-
Evidence for an Adaptive Immune Barrier after in Utero Hematopoietic Cell Transplantation.
2006
-
Gene Expression Patterns Identify Patients with Non-Small Cell Lung Cancer (NSCLC) and Ovarian Cancer Who Are at Increased Risk for Venous Thromboembolism (VTE).
2006
-
Immuno-Chemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909.
2006
-
Impaired maturation and survival of T lymphocytes, B lymphocytes, and NK cells in mice lacking Gimap5/Ian5.
2006
-
In Vivo Radiaprotective Effects of Growth Hormone.
2006
-
Interaction of activated sickle red cell LW with leukocytes induces leukocyte adhesion to endothelium via CD44-E-selectin.
2006
-
MK-0457, a novel multikinase inhibitor, has activity in refractory AML, including transformed JAK2 positive myeloproliferative disease (MPD), and in Philadelphia-positive ALL.
2006
-
MK-0457, a novel multikinase inhibitor, has activity in refractory AML, including transformed JAK2 positive myeloproliferative disease (MPD), and in Philadelphia-positive ALL.
2006
-
Mechanism of soluble laminin-mediated enhancement of sickle red cell adhesion to endothelial cells.
2006
-
Melphalan Containing Cytoreduction Results in a Good Overall Survival (OS) in Pediatric Patients with Relapse or Refractory AML Undergoing Unrelated Umbilical Cord Blood Transplantation (UCBT).
2006
-
Multivariate Analysis of Patient and Graft Specific Factors among 330 Recipients of Unrelated Cord Blood Transplant (UCBT) To Predict Risk of Death from Opportunistic Infections in the First 6 Months after UCBT.
2006
-
Preliminary Results of a Pilot Trial of Unrelated Umbilical Cord Blood Transplantation (UCBT) Augmented with Cytokine-Primed Aldehyde Dehydrogenase-Bright (ALDHbr) Cells.
2006
-
Preliminary results from the surveillance, epidemiology & risk factors for TTP (SERF-TTP) group: A prospective case-control study of idiopathic TTP.
2006
-
Prognostic Significance of Minimal Residual Disease (MRD) in Childhood B-Precursor ALL and Its Relation to Other Risk Factors. A Children’s Oncology Group (COG) Study.
2006
-
Prospective Analysis of TEL and MLL Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children’s Oncology Group Study.
2006
-
Prospective validation of a predictive model for early anemia in patients receiving cancer chemotherapy.
2006
-
Restoring initial thrombin generation does not normalize cutaneous wound healingin hemophilia B.
2006
-
Role of erythropoietin as an angiogenic factor and target in cancer.
2006
-
Testicular Relapse in Lesser, Standard, and High Risk Patients Treated with Frontline Therapy for Childhood ALL. Pediatric Oncology Group Protocols 9201, 9405, 9605, and 9406.
2006
-
Tissue Factor Is Absent from Sites of Cutaneous Wounds: Implications for Bleeding in Hemophilia.
2006
-
Unrelated donor hematopoietic stem cell transplantation (HSCT) in children with acute leukemia: Risks and benefits of umbilical cord blood (CB) versus HLAA, B, C, DRB1 allele-matched bone marrow (BM).
2006
-
Updated Cost-Effectiveness Analysis of First-Line Imatinib Compared to Interferon-α in Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Chronic Phase Using 60-Month Data from IRIS.
2006
-
Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Novel Genetic Subtypes.
2006
-
Inhibition of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-ALL after Blocking Remote 3′-BCL11B Enhancer Sequences with Matching DNA Oligos Reveals Coregulation by PU.1 and HMGA1.
2006
-
A differentiation block in erythroid cells lacking erythroid krupple-like factor (EKLF).
2005
-
A phase 2 clinical trial of AP23573, an mTOR inhibitor, In patients with relapsed or refractory hematologic malignancies
2005
-
A prospective study of bortezomib in combination with melphalan and prednisone for patients with previously untreated multiple myeloma.
2005
-
A randomized, open-label study of Lestaurtinib (CEP-701), an oral FLT3 inhibitor, administered in sequence with chemotherapy in patients with relapsed AML harboring FLT3 activating mutations: Clinical response correlates with successful FLT3 inhibition.
2005
-
A report of the event free survival (EFS) for children with newly diagnosed standard risk acute lymphoblastic leukemia (ALL) treated on pediatric oncology group (POG) protocol 9605.
2005
-
A report of the event-free survival (EFS) and neurotoxicity for children with newly diagnosed standard risk acute lymphoblastic leukemia (ALL) on pediatric oncology group (POG) protocol 9405.
2005
-
A single cell analysis of immunoglobulin genes in chronic lymphocytic leukemia (CLL): Evidence of intraclonal diversification associated with progressive somatic mutations and progressive antigen drive in immunoglobulin heavy and light chains
2005
-
ADAMTS13 levels support hypothesis of distinct mechanistic pathways for early versus late-onset of thienopyridine-associated thrombotic thrombocytopenic purpura (TTP).
2005
-
Adhesive characteristics of hemoglobin SC red blood cells.
2005
-
Antigen-specific T lymphocyte function following unrelated cord blood transplantation (UCBT).
2005
-
Blocking Complement-Mediated Hemolysis Using RNA Aptamers That Bind Complement Component C8.
2005
-
CD26 inhibition enhances allogeneic donor cell homing and engraftment after in utero bone marrow transplantation.
2005
-
Clinical and genetic profiles of the aging sickle cell patient.
2005
-
Cobalamins and Cobinamides Inhibit Nitric Oxide Synthase Enzymatic Activity.
2005
-
Combination of Daunorubicin and Cytarabine Chemotherapy with Gemtuzumab Ozogamicin as Initial Therapy for Elderly Patients with Previously Untreated Acute Myeloid Leukemia.
2005
-
Corticosteroids and Increased Risk of Readmission after Acute Chest Syndrome.
2005
-
Defibrotide (DF) for the treatment of Veno-Occlusive Disease (VOD) and multi-system organ failure (MOF) post SCT: Analysis of response and survival according to degree and type of MOV.
2005
-
Delayed wound healing in hemophilia B mice.
2005
-
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia (ALL) - Cancer and leukemia group B study 9511
2005
-
Efficacy of performing a second non-myeloablative allogenic stem cell transplant.
2005
-
Erythropoietin and erythropoietin receptor expression in early stage non-small cell lung cancer: Prognostic significance.
2005
-
Ex vivo expansion of umbilical cord blood T cells for adoptive immunotherapy.
2005
-
Gene expression patterns identify novel biologically relevant signaling and transcriptional pathways involved in terminal erythroid differentiation and polycythemia vera
2005
-
Incident TTP: Plasmapheresis therapy-related complications are common.
2005
-
Induction of chronic lymphocytic leukemia (CLL) apoptosis by nitric oxide synthase (NOS) inhibitors: Drug efficacy correlates with lipid solubility and NOS1 dissociation constant.
2005
-
Left sided heart dysfunction in sickle cell disease: Echocardiographic and genetic studies.
2005
-
Morbidity and associated sudden death in sickle cell disease.
2005
-
Multimodal dose dense therapy for mantle cell lymphoma.
2005
-
Outcome and Immune Reconstitution Following T Cell Depleted Nonmyeloablative Allogeneic Transplantation Using Matched Donors.
2005
-
Partially HLA matched, non-myeloablative allogeneic transplantation
2005
-
Pathogenic role of surface platelet factor 4 complexes in heparin-induced thrombocytopenia: Diagnostic and therapeutic implications.
2005
-
Phase I Study of Gemcitabine, Fludarabine and Mitoxantrone for Relapsed or Refractory Leukemia.
2005
-
Post-Thaw Colony Forming Unit (CFU) Counts and Yield Are the Most Important Predictors of Engraftment and Survival Following Unrelated Donor Cord Blood Transplantation (CBT): A COBLT Study Report.
2005
-
Predictors of survival in CLL: Multivariate analyses reveal significant correlation with IgV(H) gene mutation status, clinical stage, and cellular CD38 (but not Zap-70) expression.
2005
-
Priapism in SCD: Clinical and genetic correlations.
2005
-
Rapid in vivo acquisition of effector Tc1 phenotype even before myeloid engraftment predicts opportunistic infections (OI) in unrelated cord blood transplant recipients.
2005
-
Reaction of fibrinogen with homocysteine thiolactone mimics the dysfibrinogenemia produced by hyperhomocysteinemia.
2005
-
Response rates using international working group (IWG) criteria in patients with myelodysplastic syndromes (MDS) treated with azacitidine.
2005
-
Role of LW and AKAP79 in beta-adrenergic receptor signaling-induced sickle red blood cell adhesion.
2005
-
Sodium orthovanadate (NaV) effects CD22 expression, intracellular signaling, and lymphomacidal activity of the HB22.7 anti-CD22 monoclonal antibody.
2005
-
The relationship of plasma laminin levels to anemia and the effect of soluble laminin on sickle red cell adhesion in SCD.
2005
-
Thrombotic and hemorrhagic events for patients on pediatric oncology group (POG) protocols 9201, 9605, 9406.
2005
-
Transplant Outcomes and Stabilization of Neurological Function in Young Children with MPS III (Sanfilippo Syndrome) after Unrelated Donor Umbilical Cord Blood Transplantation.
2005
-
Unique Reversible but Serious Adverse Events in Very Young Infants Undergoing Unrelated Donor Umbilical Cord Blood Transplantation for Non-Malignant Conditions: Increased Autoimmune Cytopenias and Hypertrophic Cardiomyopathy.
2005
-
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.
2005
-
Are There Two Distinct Mechanistic Pathways That Explain the Varying Clinical Presentations, Laboratory Findings, and Outcomes of Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura (TTP)?.
2004
-
Blocking Complement-Mediated Hemolysis of PNH Erythrocytes by RNA Aptamers to C8 and C9.
2004
-
CALGB 59901: Results of a phase II study of 506U78 in CTCL and PTCL.
2004
-
CALGB 90003: Adoptive Immunotherapy by Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Carcinoma: An Intergroup Phase II Study.
2004
-
COAT Platelet Formation Is P2Y12-Dependent.
2004
-
Campath-1H May Have Activity in the Treatment of Multiple Myeloma.
2004
-
Characterization of autoantibodies to PF4/heparin in a rat model of cardiopulmonary bypass.
2004
-
Comparison of Diagnostic and Relapse Flow Cytometry Phenotypes in Childhood ALL: Implications for Residual Disease (MRD) Detection.
2004
-
Cord Blood Transplantation for Lysosomal Storage Diseases Demonstrates the Potential of Cord Blood Cells for Future Cellular Therapies.
2004
-
Cord blood (CB) bank log CD34(+) and CD34(+) subsets (CD38(-)CD61(+)CD90(+)) are significantly correlated to log total CFU, CFU-GEMM, CFU-GM and BFU-E: A report from the COBLT program
2004
-
Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Final Results of a Phase II, Multicenter, Randomized Study and Preliminary Analyses of Surrogate Markers and Ultrasound Findings.
2004
-
Dendritic and T Cell Subsets Correlate with the Development and Site of Acute GVHD Following Unrelated Cord Blood Transplantation. A Multivariate Analysis of Host, Graft, and Day+50 Immune Profile.
2004
-
Dose Dense, High Intensity Induction Therapy Followed by Early High Dose Chemotherapy (HDT) and Autologous Hematopoietic Stem Cell Transplantation(AHSCT) for Mantle Cell Lymphoma (MCL).
2004
-
Dose dense, high intensity therapy in newly diagnosed elderly patients with acute myeloid leukemia using gemtuzumab ozogamicin (Mylotarg (TM)) and high dose cytarabine (HiDAC).
2004
-
Effects of Pre-Analytical Variables on the Anti-FXa Chromogenic Assay when Monitoring Unfractionated Heparin and Low Molecular Weight Heparin Anticoagulation.
2004
-
Effects of Single Nucleotide Polymorphisms of the β2 Adrenergic Receptor and of Adenylate Cyclase on Sickle Red Cell Adhesion to Laminin.
2004
-
Epinephrine-Induced Sickle Red Cell Adhesion and Vaso-Occlusion In Vivo Is Inhibited by the β-Adrenoceptor Blocker Propranolol.
2004
-
Establishment of the NMDP Cord Blood Banking Network.
2004
-
Ex vivo gene therapy of a preadolescent with x-linked severe combined immunodeficiency
2004
-
First Cycle Risk of Severe and Febrile Neutropenia in Cancer Patients Receiving Systemic Chemotherapy: Results from a Prospective Nationwide Study.
2004
-
Gemtuzumab ozogamicin (Mylotarg (R)) as primary induction therapy for elderly patients with acute myeloid leukemia: A phase II trial
2004
-
Genetic Polymorphisms Associated with Risk for Pulmonary Hypertension and Proteinuria in Sickle Cell Disease.
2004
-
Hematopoietic Cell Transplantation for Sickle Cell Disease: Updated Results of the Multicenter Trial.
2004
-
Heparin-induced thrombocytopenia is a thymus (T cell) dependent disorder.
2004
-
High Expression of Granzymes and Perforin along with Increased T cell Cycling In Vivo Predicts the Development of Opportunistic Infections (OI) Following Unrelated Cord Blood Transplantation (UCBT).
2004
-
Human memory T cells proliferate but do not elicit cytotoxicity in response to alloantigens.
2004
-
Hypoxic Vasodilation by Red Blood Cells and Impairment in Vascular Disorders.
2004
-
Immunophenotype and Analysis of Allo-Reactivity of Umbilical Cord Blood (UCB)-Derived T-Cells Following Ex-Vivo Expansion.
2004
-
Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report.
2004
-
Multimodal Dose Dense Therapy for Mantle Cell Lymphoma.
2004
-
Pharmacogenetics of minimal residual disease response in children with acute lymphoblastic leukemia (ALL).
2004
-
Phase II Study of Thalidomide in Escalating Doses for Follicular (F-NHL) and Small Lymphocytic Lymphoma (Sll): CALGB Study 50002.
2004
-
Point of Care Monitoring of the International Normalized Ratio in Patients with Antiphospholipid Antibodies.
2004
-
Preliminary Findings from the Prospective Multicenter Surveillance, Epidemiology and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) Study.
2004
-
Promotion of stem cell-derived new T cell generation by CD62L-memory T cells requires alloantigen recognition.
2004
-
Protein Kinases Associated with Activation of Sickle Red Blood Cell Adhesion.
2004
-
Pulmonary Hypertension in SS, SC and Sβ Thalassemia: Prevalence, Associated Clinical Syndromes, and Mortality.
2004
-
Recryopreserved and rethawed aliquots with anti-CD3, IL-2, IL12 significantly expands NKT cells, NKT KIR substes and NK cytotoxicity compared to short-term expansion: Potential for CB adoptive cellular immunotherapy (ACI).
2004
-
Red Blood Cell S-Nitrosohemoglobin Deficiency in Pulmonary Arterial Hypertension.
2004
-
Risk Factors for Intracranial Hemorrhage in Children with Sickle Cell Anemia.
2004
-
Sequential Topoisomerase I (Topo I) and Topoisomerase II (Topo II) Inhibitors in Relapsed/Refractory Aggressive NHL: Results of CALGN 59906, a Phase II Study of Doxorubicin and Topotecan.
2004
-
Specialized Bone Marrow Endothelium Defines Microdomains for Tumor and Stem Cell Engraftment.
2004
-
The Impact of Anemia on Mortality, Cognition and Function in a Racially Diverse Community-Dwelling Elderly Population.
2004
-
The use of DT388-IL3 fusion protein in patients with refractory acute myeloid leukemia(AML)
2004
-
Thrombocytopenia Is More Common and Nadir Occurs Earlier with Unfractionated Heparin Than with Low Molecular Weight Heparin - Results from the Prospective Catch Registry.
2004
-
Validation of a Risk Model for Hospitalized Adult Cancer Patients with Febrile Neutropenia.
2004
-
A cost-effectiveness evaluation of imatinib versus interferon-alpha plus low-dose Ara-C for first-line treatment of patients with newly diagnosed chronic myeloid leukemia in the chronic phase.
2003
-
A novel method for ex-vivo expansion of NKCD3-/CD16+/56(+bright/dim) subjects expressing increased inhibitory receptors from cryopreserved/thawed/expanded/recryopreserved (CTECT) umbilical cord blood (UCB) using anti-CD3, IL-2, IL-7, and IL-12 (AB/CY): Implications for adoptive cellular immunotherapy (ACI) post umbilical cord blood transplantation (UCBT)
2003
-
A single cell analysis of immunoglobulin genes in chronic lymphocytic leukemia (CLL): Progressive somatic mutations in the immunoglobulin heavy and light chains contribute to intraclonal diversification in CLL.
2003
-
Activity of compound 506U78 in patients with refractory T-cell malignancies: A POG/CCG intergroup phase 2 study.
2003
-
B-CAM/LU polymorphisms: Effect on sickle cell disease outcomes and cell adhesion.
2003
-
Bronchiolitis obliterans organizing pneumonia (BOOP) after bone marrow transplantation (BMT) for sickle cell disease (SCD): Association with acute chest syndrome (ACS).
2003
-
Characterization of neuronal/glial differentiation of murine adipose-derived adult stromal cells.
2003
-
Chronic lymphocytic leukemia cells (CLL) express the neuronal isoform of nitric oxide synthase (NOS1), and NOS1-specific inhibitors induce CLL cell death.
2003
-
Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy from HLA matched siblings.
2003
-
Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy using HLA mis-matched (3-5/6) related hematopoietic stem cells.
2003
-
Clopidogrel-associated TTP: Comparison of quality and timeliness of case reports obtained from the FDA, the pharmaceutical supplier, and from active pharmacovigilance.
2003
-
Clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): Clinical characteristics and predictors of survival.
2003
-
Combined infusion of peripheral blood stem cells (PBSC) plus bone marrow (BM) in poorly mobilizing patients undergoing high-dose therapy (HDT) and autologous stem cell transplant (ASCT)
2003
-
Complement-mediated hemolysis of erythrocytes is blocked by RNA aptamers to complement components C5 and C8.
2003
-
Defibrotide (DF) is effective in the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Results of a phase II, multicenter, randomized study.
2003
-
Dose-intense cyclophosphamide and etoposide for patients with refractory or high risk non-Hogdkin's lymphoma.
2003
-
Ex vivo expansion of umbilical cord blood (UCB) derived immature and mature T cells.
2003
-
Examination of a VCAM1 polymorphism as a risk modifier for clinical outcomes in sickle cell disease.
2003
-
Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation.
2003
-
In vitro exposure to epinephrine causes in vivo adhesion of human sickle red blood cells to vascular endothelium in nude mice: A new model for studying vaso-occlusion.
2003
-
Incidence, characteristics, and treatment of DVT in pregnant and postpartum women from the DVT FREE registry.
2003
-
Isolation of oligodendrocyte precursors from umbilical cord blood.
2003
-
Low-dose weekly paclitaxel for relapsed or refractory aggressive non-Hodgkins lymphoma.
2003
-
One day preparative regimen for allogeneic non-myeloablative stem cell transplantation (NMSCT) using 3-5/6 HLA matched related donors.
2003
-
Outcomes of 138 adult and pediatric patients undergoing cord blood transplantation from large cord blood bank.
2003
-
Pharmacokinetics of subcutaneous alemtuzumab in a patient with myeloma.
2003
-
Phase I trial with pharmocokinetics, dosimetry, toxicity and response of anti-stromal therapy using I-131 labeled chimeric anti-tenascin therapy for lymphoma.
2003
-
Phase one evaluation of gemcitabine, fludarabine, and mitoxantrone for relapsed or refractory leukemia.
2003
-
Platelet transmission electron microscopy in genetically confirmed MYH9-related disorders.
2003
-
Platelets stimulated with convulxin plus thrombin develop platelet subpopulations with increased binding of factor VIII, factor IX, and factor X.
2003
-
Preliminary results of unrelated umbilical cord blood transplantation for Sanfilippo syndrome (MPS III).
2003
-
Protein phosphatase inhibitors as potent cytotoxic agents for B-cell CLL in vitro.
2003
-
Results of the cord blood transplantation study (COBLT) unrelated donor banking program from donor screening to characterization of banked units.
2003
-
Risk assessment for hepatic veno-occlusive disease in patients treated with gemtuzumab ozogamicin (Mylotarg (R)) with or without hematopoietic stem cell transplantation.
2003
-
Sickle RBCs form microaggregates in autologous plasma following epinephrine stimulation: A role for endogenous, soluble laminin.
2003
-
Splenectomy prior to umbilical cord blood (UCB) transplantation facilitates hematologic engraftment in pediatric and adult patients.
2003
-
Successful treatment of pure red cell aplasia (PRCA) with alemtuzumab (CAMPATH-1H).
2003
-
TEPA augments the ex-vivo and in-vivo potential of cord blood derived CD34+cells: From basic science to clinical trials.
2003
-
The interaction of platelets and endothelial cells modulates the procoagulant/anticoagulant balance in heparin-induced thrombocytopenia.
2003
-
The small GTPase rapl activates BCAM/LU-dependent but not alpha 4 beta l-dependent adhesion in sickle red blood cells: Evidence for divergent adhesive pathways.
2003
-
Thrombocytopenia is common among patients treated with heparin and is rarely detected and evaluated with serologic testing and hematology consultation: Preliminary findings from the CATCH registry.
2003
-
Umbilical cord blood cells engraft and differentiate in cardiac tissues after human transplantation.
2003
-
Unrelated donor umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
2003
-
cAMP-dependent activation of sickle red blood cell adhesion is associated with LW serine and tyrosine phosphorylation.
2003
-
A phase II, open-label study of CLOPAREX(TM) in adult patients with refractory or relapsed acute myelogenous leukemia
2002
-
Ability of minority patients to find donors from an ethnically diverse cord blood bank.
2002
-
Anti-CD3/IL-2/IL-7/IL-12 ex-vivo expansion of previously cryopreserved and subsequent recryopreservation of umbilical cord blood (UCB) cytotoxic T lymphocytes: A new procedure for adoptive cellular immunotherapy (ACI) post UCB transplant (T).
2002
-
B-CAM/LU mediates laminin-independent cell-cell adhesion under both static and flow conditions.
2002
-
Campath-1H, T cell depleted nonmyeloablative peripheral blood stem cell transplantation from 3-6/6 HLA matched family members.
2002
-
Chronic lymphocytic leukemia (CLL) cell CD38 expression and inducible nitric oxide synthase (NOS2) expression are associated with serum IL-4 levels.
2002
-
Clinical evaluation of retroviral vectors for corrective gene transfer of adenosine deaminase (ADA) deficiency.
2002
-
Correction of congenital immunodeficiency disease with umbilical cord blood transplantation.
2002
-
Defibrotide (DF) appears effective and safe in a phase II, randomized study of patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT).
2002
-
Donor chimerism after T-Cell depleted (TCD)-Non-Myeloablative allogeneic SCT (NST) in hemoglobinopathies.
2002
-
Donor-specific tolerance after hematopoietic reconstitution with Campath-1H treated mobilized peripheral blood cells in a sublethal preconditioning regimen.
2002
-
Early T cell reconstitution along with graft and patient characteristics impact on opportunistic infections following unrelated cord blood transplantation in children.
2002
-
Elevated expression of numerous interferon inducible genes in primary bone marrow cells expressing p185 Bcr-Abl versus p210 Bcr-Abl by DNA microarray analysis.
2002
-
Ex vivo expansion of CB derived AC 133 progenitor cells with a polyamine copper chelator: Pre-clinical data.
2002
-
Ex vivo propagation and expansion of umbilical cord blood derived immature and mature T-cells.
2002
-
Failure of a minimally toxic non-myeloablative regimen to establish stable donor engraftment after transplantation for sickle cell anemia and beta-thalassemia.
2002
-
Fatal rapidly progressive liver disease associated to a novel mutation of the perforin gene.
2002
-
Final results of a multivariate logistic regression analysis to determine factors contributing to the risk of developing hepatic veno-occlusive disease (VOD) following treatment with gemtuzumab ozogamicin.
2002
-
GLAT (Copaxone) for treatment of steroid-refractory acute graft versus host disease.
2002
-
Gene expression profiling of AAV serotype 1-5 vectors in adult and neonatal animals using in vivo bioluminescence imaging.
2002
-
Immunological and clinical responses in patients with metastatic renal cell carcinoma to vaccination with tumor RNA transfected dendritic cells.
2002
-
Immunophenotypic and functional characterization of CD4+ CD25+ regulatory T cells as a function of aging in normal human peripheral blood and autoimmune disease.
2002
-
In vitro priming and generation of cytomegalovirus-specific T cell responses from umbilical cord blood.
2002
-
In vivo engraftment and differentiation of murine adipose derived stromal cells.
2002
-
Intracellular inositol polyphosphatides signaling via factor VIIa and factor X: The possible role of protease-activated receptor 2 and tissue factor activation.
2002
-
Modulation by epinephrine of PKA-dependent signaling pathways in sickle red blood cells induces activation of LW binding to endothelial cell alpha v beta 3 integrin.
2002
-
Morpholino antisense oligomer to integrin alpha, inhibits angiogenesis in a mouse model of retinopathy of prematurity.
2002
-
Nucleated cell count and CD34+count similar between cord blood units collected from Caucasian and non Caucasian umbilical cord blood donors.
2002
-
Patients with refractory B-CLL and T-PLL treated with alemtuzumab (Campath (R)) on a compassionate basis. A report on efficacy and safety of CAM 511 trial.
2002
-
Philadelphia-chromosome (Ph+) acute lymphoblastic leukemia (ALL) in children and adolescents: Outcome with unrelated placental cord blood (PCB) transplantation.
2002
-
Preliminary analysis of a randomized phase 2 study of the safety and efficacy of 1 vs. 2 doses of gemtuzumab ozogamicin (Mylotarg (R)) in patients with high risk myelodysplastic syndrome.
2002
-
Racial/ethnic diversity achieved in national network of cord blood banks.
2002
-
Relationship of sickle red blood cell laminin binding to disease activity.
2002
-
Successful treatment of lymphoma xenografts with the anti-CD22 mAb HB22.7 alone and augmented response when given with Y90-DOTA-PEPTIDE-LYM-1 that is sequence specific.
2002
-
Three methods of T-cell depletion of HPCT products: Analysis of CD34+ cell and lymphocyte purity and recovery.
2002
-
Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT): 2 year follow-up.
2002
-
Treatment of severe systemic sclerosis with allogenic marrow transplantation.
2002
-
Unrelated umbilical cord blood (UCB) transplantation for infants with acute lymphoblastic leukemia (ALL) and rearrangements of the 11q23 chromosomal region.
2002
-
Unrelated umbilical cord blood transplant for Wiskott-Aldrich syndrome.
2002
-
Updated results of bone marrow transplantation (BMT) for sickle cell disease (SCD): Impact on CNS disease.
2002
-
Effect of hyperhomocysteinemia on protein C activation and activity in vivo.
2001
-
Enumerating functionally mature monocyte-derived dendritic cells for use in cancer immunotherapy.
2001
-
High dose factor VIIa enhances clot stability in a model of hemophilia.
2001
-
Quantitating antigen specific T cell responses in peripheral blood: A comparison of peptide MHC tetramer, ELISpot and intracellular cytokine analysis.
2001
-
Dendritic cell (DC) reconstitution after nonmyeloablative allogeneic stem cell transplants
2000
-
Multilineage hematopoietic development from umbilical cord blood cells with high aldehyde dehydrogenase activity
2000
-
Addition of stem cells from allogeneic donors accelerates engraftment and immune reconstitution after stem cell transplantation.
2000
-
Dendritic cell (DC) reconstitution after non-myeloablative allogeneic stem cell transplants.
2000
-
Hematopoiteic stem cell doses correlate with the speed of immune reconstitution after allogeneic stem cell transplantation.
2000
-
Hyperhomocysteinemia induces alterations in fibrinogen function and fibrin clot structure in a rabbit model.
2000
-
Hyperhomocysteinemia induces monocyte tissue factor (TF) expression in vivo.
2000
-
Multiple signals are required for IL-12 production by Flt-3 ligand mobilized dendritic cells.
2000
-
Prolonged disease-free survival in patients with acute myeloid leukemia in first relapse treated with gemtuzumab ozogamicin (Mylotarg (TM), CMA-676) followed by hematopoietic stem cell transplantation.
2000
-
V beta repertoire of T lymphocytes emerging in adults after unrelated umbilical cord blood (UCB) allogeneic transplantation.
2000
-
Activated protein C (APC) functions by inhibiting initiation of coagulation rather than by terminating a hemostatic response.
1999
-
De-encryption of cellular tissue factor is independent of its cytoplasmic domain.
1999
-
Efficacy and safety of CMA-676 in patients with AML in first relapse.
1999
-
FLT3-ligand (FLT3L) mobilization of dendritic cells (DC) in patients with metastatic colon cancer.
1999
-
Impaired immune function in murine adult cord blood recipients.
1999
-
Reconstitution of the immunohematopoietic system in adult murine recipients across major histocompatibility complex by near-term fetal blood.
1999
-
Residual trisomic cells in a patient with resolving transient myeloproliferative disorder and trisomy 21 mosaicism.
1999
-
The initial rate, but not the total amount, of thrombin (IIa) generated determines fibrin clot structure in a cell-based model of coagulation.
1999
-
Tissue factor independent effect of high dose factor VIIa directly correlates with factor X levels.
1999
-
Inhibition of alloreactive T cell expansion in vivo by PG490-88 results in successful prevention of graft-versus-host disease (GVHD).
1998
-
Transformation of chronic lymphocytic leukemia (CLL) to Hodgkin's disease (ZED) - A treatable entity.
1998
-
Transforming properties of the P185, P210 and P230 variants of BCR/ABL in primary mouse bone marrow.
1998
-
V beta repertoire of T lymphocytes emerging after unrelated umbilical cord blood (UCB) transplantation.
1998
-
Activated platelets provide a surface for the activation of factor XI by thrombin and factor Xa.
1997
-
Cloning and characterization of the chronic neutrophilic leukemia-associated P230 BCR/ABL oncogene.
1997
-
Co-localization of factor IX and collagen type IV in human vascular tissues.
1997
-
Competition between factors X and IX for activation by f.VIIa/tissue factor (TF): Effect on thrombin (IIa) production in a cell-based model.
1997
-
De-encryption of cellular tissue factor (TF) activity increases activation of both factors IX & X.
1997
-
Generation of autologous CD4+ T lymphocyte clones specific for precursor-B (pre-B) lymphoblasts via dendritic cell (DC) presentation
1997
-
Abnormal tyrosine phosphorylated 30 kDa protein in a patient with immunodeficiency and severe encephalopathy associated with a constitutive activation of the MAPK cascade.
1996
-
Generation of T lymphocyte clones specific for acute lymphoblastic leukemia (ALL) via dendritic cell (DC) presentation.
1996
-
High dose factor VIIa promotes thrombin generation on activated platelets in the absence of tissue factor.
1996
-
Peg-L-Asparaginase (PL-A) in advanced multiple myeloma (MM): A novel agent with therapeutic potential.
1996
-
The effect of active site-inhibited coagulation factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin treatment.
1996
-
Active site-inhibited coagulation factor VIIa blocks platelet activation, thrombin generation, and accumulation of platelet-bound factor X in a tissue factor-initiated system.
1995
-
CD83 is a marker for mature dendritic cells (DC) generated from peripheral blood mononuclear cells (PBMC)
1995
-
Coagulation factor XIa enhances the binding of both zymogen and activated factor IX to stimulated human platelets.
1995
-
Comparing effects on temperature of early versus late leukodepletion in platelet transfusions.
1995
-
Ex vivo generation of antigen specific T cell populations for the treatment of infectious diseases and cancer.
1995
-
Gene-transfected leukemia vaccines in acute lymphoblastic leukemia (ALL).
1995
-
Liposome-mediated gene-transfection of human precursor-B lymphoblasts.
1995
-
FACTOR IXA AND FACTOR XA PLAY DISTINCT ROLES IN TISSUE FACTOR-DEPENDENT INITIATION OF COAGULATION
1994
-
PATHOGENESIS OF TRANSPLANT-ASSOCIATED B-CELL LYMPHOMAS DIFFERS FROM THOSE ASSOCIATED WITH AIDS
1994
-
GENE-THERAPY FOR NEONATES WITH ADA-DEFICIENT SCID BY RETROVIRAL-MEDIATED TRANSFER OF THE HUMAN ADA CDNA INTO UMBILICAL-CORD CD34+ CELLS
1993
-
HEMATOPOIETIC ENGRAFTMENT FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) WITHOUT CYTOREDUCTION IN A CHILD WITH SEVERE COMBINED IMMUNE-DEFICIENCY (SCID)
1993